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1. Introduction  
 
1.1 The actin cytoskeleton 
 
Cells, the basic unit of life, have the remarkable ability to change shape, divide, and 
move. These vital functions are powered by a dynamic assembly known as the 
cytoskeleton (Fletcher & Mullins, 2010). Eukaryotic cells contain three main types of 
cytoskeletal filaments: microfilaments, intermediate filaments, and microtubules. Actin 
filaments are the thinnest of the cytoskeletal filaments with a diameter of approximately 
6-8 nm (Cooper, 2000). Various important cellular functions such as migration, invasion, 
endocytosis, adhesion, and cytokinesis require the rearrangement and remodeling of the 
actin cytoskeleton (Egea, Serra-Peinado, Salcedo-Sicilia, & Gutiérrez-Martínez, 2013; 
Nurnberg, Kitzing, & Grosse, 2011; Olson & Sahai, 2009; Parsons, Horwitz, & Schwartz, 
2010; Pollard & Cooper, 2009). 
 
Actin is a 42 kDa globular, highly conserved, and most abundant cytoskeletal protein in 
eukaryotic cells (Pollard, 2016). Actin exists in two different forms, globular and 
filamentous actin. G-actin is a globular monomer of 375 amino acids with a pointed and 
barbed end. G actin monomers polymerize to form actin filaments (Lee & Dominguez, 
2010). Actin filament polymerization occurs over three phases: a nucleation phase, an 
elongation phase, and a steady state phase. During nucleation, three actin monomers 
usually form a trimer otherwise called ‘‘actin nucleus’’ (Sept & McCammon, 2001). In the 
elongation phase, monomers are rapidly added to the filament. Polymerization is 
reversible and proceeds from both ends to yield F-actin, a helical polymer. F-actin has 
structural polarity, a pointed (-) end and a barbed (+) end. The filament grows at both 
ends but growth is faster at the barbed (+) end (Pollard, 2016). 
 
 
Figure 1. Actin filament treadmilling regulation. 
 
Actin fibers are formed of 2 chains of polar actin subunits arranged in a double helix. Profilin forms 
a complex with ATP-actin, which directs actin monomers to the barbed ends. Upon ATP 
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exchange, ADP-actin dissociates from the pointed end. Factors such as ADF/Cofilin increase the 
rate of dissociation of ADP-actin at the pointed end. Adapted from MBInfo, 2018. 
 
Actin filaments undergo treadmilling where there is a net gain of subunits on the barbed 
end and an equivalent net loss of subunits on the pointed end. ATP-binding on actin 
subunits modulates the dynamics of filament assembly, with ATP-binding generally 
favoring inter-subunit interactions and thereby filament assembly. At high free ATP-G-
actin concentrations, the rate of addition exceeds the rate of dissociation and this results 
in actin filament growth. Soon after polymerization, ATP is hydrolyzed to ADP + Pi.  ADP 
bound actin which is primarily at the pointed end of the filament, dissociates more readily 
than ATP bound actin (Fig.1). Hence, ATP binding and hydrolysis play a key role in the 
dynamic behavior of actin filaments (Bugyi & Carlier, 2010; Otterbein, Graceffa, & 
Dominguez, 2001).  
Different types of actin binding proteins remodel or modify existing filaments. These 
include, among others, profilin and cofilin (Dos Remedios et al., 2003). Profilin catalyzes 
the exchange of bound ADP for ATP resulting in ATP-actin monomers which readily 
assemble into filaments. Cofilin binds to actin to enhance the rate of dissociation of ADP-
actin monomers from the pointed end. It can also sever actin filaments creating new 
barbed and pointed ends (Bindschadler, Osborn, Dewey, & McGrath, 2004). Actin 
filaments can be organized into bundles or networks via cross-linking proteins (Tseng et 
al., 2005). These filaments can form stress fibers and are involved in forming 
lamellipodia, filopodia, or blebs (Fig.2). All of which have distinct roles in the actin 
cytoskeleton function (Le Clainche & Carlier, 2008). Stress fibers are higher order 
cytoskeletal structures composed of crosslinked actin filament bundles (Hotulainen & 
Lappalainen, 2006). Lamellipodia are sheet-like protrusions characterized by a branched 
actin network, typically observed at the leading edge of motile cells (Zimmermann & 
Falcke, 2014). Filopodia differ structurally from lamellipodia, they are finger-like 
extensions of the plasma membrane characterized by parallel arrays of F-actin 
generated at the tip of the filopodium (Katharina Grikscheit & Grosse, 2016). Finally, 
blebs are blister-like protrusions that occur at the cell surface (Charras, Hu, Coughlin, & 
Mitchison, 2006). The assembly and disassembly of actin filaments rapidly responds to 
extracellular signals and is tightly controlled (Lee & Dominguez, 2010).  
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Figure 2. Cellular actin organization. 
 
Schematic representation of actin-containing structures found in the cell. Zoomed regions 
highlight the specific actin organization of lamellipodium, filopodium, and stress fibers. Adapted 
from (Blanchoin, Letort, Ennomani, Gressin, & Théry, 2015). 
 
1.2 Regulation of actin nucleation/polymerization 
 
De novo actin filament formation is kinetically unfavorable and requires the involvement 
of one of the three major classes of actin nucleators in addition to nucleation promoting 
factors (NPF) (Fig.3) (Chesarone & Goode, 2009). The actin-related protein 2/3 (Arp2/3) 
complex and the formin homology proteins are the most commonly described nucleators. 
The third group, known as tandem-monomer-binding nucleators includes the Spire 
proteins, Cordon-bleu (Cobl), Leiomodin (Lmod-2), adenomatous polyposis coli (APC), 
and junction-mediating regulatory protein (JMY). While all three classes are capable of 
nucleating G-actin and are involved in the polymerization of actin filaments, their 
individual mechanisms are rather distinct (Campellone & Welch, 2010).  
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Figure 3. Different actin nucleator classes. 
 
The spontaneous nucleation of actin to assemble into filaments is kinetically unfavorable (a). 
Examples of the three main actin nucleators, the actin-related protein-2/3 (Arp2/3) complex, spire, 
and formins bypass the need for spontaneous nucleation. Each promotes nucleation by a distinct 
mechanism. The Arp2/3 complex mimics an actin dimer or trimer to function as a template for the 
initiation of a new branched actin filament (b). Spire proteins interact with formin 2 to recruit actin 
monomers through their WH2 domain and nucleate the assembly of linear, unbranched actin 
filaments (c). Formins promote the nucleation of unbranched filaments (d). Studies indicate that 
they function as dimers to stabilize actin dimers or trimers to facilitate nucleation. Furthermore, 
they remain associated with the growing barbed ends of filaments. WH2: WASP-Homology 2, 
NPF: nucleation-promoting factor. Modified from (Goley & Welch, 2006) 
 
 
1.2.1 The Arp2/3 complex and branched nucleation 
 
The Arp2/3 complex was the first nucleating factor to be discovered (Machesky, 
Atkinson, Ampe, Vandekerckhove, & Pollard, 1994). It is composed of seven subunits: 
Arp2, Arp3, and ARPC1-5. It is conserved in almost all eukaryotes. Arp2/3 binds near 
the barbed ends of a pre-existing ‘‘mother’’ filament and forms a new ‘‘daughter’’ branch 
with a 70 degree angle (Rouiller et al., 2008; Volkmann et al., 2001). The Arp2/3 complex 
is activated by nucleation promoting factors such as WASP (Wiskott-Aldrich Syndrome 
protein), N-WASP (N:neuronal), WAVE/Scar (WASP family Verprolin-homologues), 
WASH (WASP and Scar homologue), and cortactin (Goley, Rodenbusch, Martin, & 
Welch, 2004). WASP, for example, exists in an auto-inhibited state until it is activated by 
CDC42 which binds to the GBD (GTPase binding domain), displacing the WCA domains 
(Erfei & Zigmond, 1999; Prehoda, Scott, Mullins, & Lim, 2000) (Fig.4). The WCA domain 
interacts with the Arp2/3 complex, specifically Arp2 and Arp3. This will induce a 
conformational change in each of the seven subunits enabling G-actin to bind to the 
complex. The newly nucleated daughter filament will continue to grow by polymerization 
(Goley & Welch, 2006).  
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Figure 4. Arp2/3 mediated actin polymerization. 
 
NPFs such as N-WASP mediate Arp2/3 F-actin assembly. The W region delivers actin monomers 
to the Arp2/3 nucleation machinery, whereas the C and A regions bind and activate the Arp2/3 
complex. This leads to the assembly of a branched actin filament. Modified from (Ireton, 2013) 
 
1.2.2 Formins and other nucleators 
 
Formins are the largest group of actin nucleators and are highly conserved in animals, 
plants, and fungi. Formins are potent actin regulators which are able to directly nucleate 
and/or elongate actin filaments (Goode & Eck, 2007). They nucleate and polymerize actin 
filaments at focal adhesions at a rate of around 0.3 µm/min . Inhibiting formin protein 
expression results in a decreased filament elongation rate (0.1 µm/min), coupled with 
abnormal stress fiber morphology and an accumulation of actin binding proteins (i.e. -
actinin) (Hotulainen & Lappalainen, 2006). Formins nucleate long unbranched actin 
filaments (Chesarone & Goode, 2009). Furthermore, in the case of many formins (i.e. 
mDia1), they remain associated with the barbed end during filament elongation and 
presumably prevent the binding of capping proteins (Mizuno, Tanaka, Yamashiro, Narita, 
& Watanabe, 2018). 
The tandem-monomer-binding nucleators possess repeats of G-actin binding motifs. 
Common to all these proteins are repeats of the actin binding motif (WASp)- homology 
2 (WH2) domain. However, additional actin binding motifs may be present in the 
individual members. This provides variation in their mechanisms of nucleation and in the 
cellular functions they facilitate (Dominguez, 2016). 
 
1.3 The formin homology protein family 
 
There are 15 different formin protein members in mammals which can be divided 
phylogenetically into seven subgroups (Fig.5). The major feature of formins is the highly 
conserved C-terminal formin homology 2 (FH2) domain, which is essential for driving 
actin dynamics (Faix & Grosse, 2006). Because of their role in remodeling the actin 
cytoskeleton and regulating microtubule dynamics (Chesarone, DuPage, & Goode, 
2010), formins are crucial for cellular processes like migration, cytokinesis, and organelle 
trafficking (Young & Copeland, 2010). 
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Figure 5. Domain organization of the seven mammalian formin subfamilies. 
 
Formin subfamilies are classified based on the sequence similarity of the critical actin-nucleating 
FH2 domain. GBD: GTPase-Binding Domain. DID: Diaphanous Inhibitory Domain. FH1: Formin 
Homology 1 domain. FH2: Formin Homology 2 domain. DAD: Diaphanous Autoregulatory 
Domain. FRL is synonymous with FMNL. Modified from (Campellone & Welch, 2010) 
 
1.3.1 Actin assembly by formins 
 
The FH2 domain of formins initiates the nucleation of new actin filaments by stabilizing 
pre-existing actin dimers/ trimers. Two FH2 domains form an anti-parallel donut-shaped 
homodimer and associate with the barbed end of actin filaments (Fig.6).The current 
model suggests that formins processively stair-step at the end of elongating actin 
filaments to incorporate profilin-actin, while forming a donut-shaped structure 
(Courtemanche, 2018). Ena/VASP proteins support formin-mediated filament elongation 
by tethering the filaments near sites of active actin assembly (Breitsprecher et al., 2011). 
The mechanism by which the FH2 domain functions as a processive cap is not yet fully 
established and hence remains a working model (Goode & Eck, 2007). During the 
process of actin filament elongation, the dimerized FH2 domains undergo conformational 
changes (Fig.6). In the open conformation, one FH2 domain takes a step towards the 
barbed end of the filament, either before or after G-actin incorporation. After the second 
FH2 domain repeats this step, both FH2 domains adopt a closed conformation and 
remain associated with the barbed end. In several formin proteins, a proline rich FH1 
domain is located N-terminally in front of the FH2 domain. The FH1 domain is able to 
bind profilin and hence recruit ATP-bound profilin-G-actin complexes to the FH2 domain, 
accelerating further polymerization at the barbed end.  
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Figure 6. Formin-mediated actin filament polymerization model.  
 
The FH2 dimer associates with the barbed end of the actin filament (1). The profilin-G-actin 
complex can bind to the flexible FH1 domain of formin and then transfer rapidly onto the end of 
the growing filament. The FH2 domain steps reliably onto the new actin subunit (2). The second 
FH2 repeats this process (3). The formin closed confirmation prevents capping by other factors 
(4). Modified from (Campellone & Welch, 2010) 
 
The ability of individual formins to nucleate actin, associate with barbed ends, or interact 
with profilin varies remarkably between the different formins. For example, INF2 
nucleates actin, but also causes actin severing and disassembly (Chhabra & Higgs, 
2006). mDia2, on the other hand binds to the barbed ends of actin filaments and 
promotes strong polymerization activity (Kühn & Geyer, 2014). Even though formins 
share a common mechanism in actin polymerization, we still find substantial differences 
in their actin assembly abilities (Kovar & Pollard, 2004). 
 
1.3.2 Formin domain organization and regulation 
 
Diaphanous-related formins (DRFs) are the prototypic formins, and are effectors of Rho 
family GTPases. They encompass the four mammalian families mDia, Daam, FHOD, 
and FMNL that share a similar domain organization (Baarlink, Brandt, & Grosse, 2010). 
This includes a GTPase binding domain at the N-terminus adjacent to a Diaphanous-
inhibitory domain (DID) and a dimerization domain (DD). The C-terminus comprises the 
FH1, FH2 domain, along with the Diaphanous-autoregulatory domain (DAD) (Faix & 
Grosse, 2006) (Fig.5). The interaction between the DID and the DAD of DRFs results in 
a basal, autoinhibited state, which can be released by the binding of an active Rho 
GTPase to the GBD. This allows the DID to undergo a conformational change and 
release the DAD (Lammers, Rose, Scrima, & Wittinghofer, 2005). It is proposed that the 
autoinhibitory interaction of the DID and DAD sterically prevents FH2 from contacting 
actin (Paul & Pollard, 2009). There are also several formins which are not autoregulated, 
for example mammalian Delphilin, INFs, and FMNL3 (Chhabra & Higgs, 2006; Miyagi et 
al., 2002; Vaillant et al., 2008).  In addition to Rho GTPase binding, release of 
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autoinhibition can also be accomplished by post-translational modifications. It has been 
shown that several formins are regulated via serine-threonine phosphorylation involving 
various kinases such as Rho-dependent protein kinase (ROCK), aurora kinase, or PKC 
isoenzymes (Iskratsch et al., 2013; Shimada et al., 2004; Takeya, Taniguchi, Narumiya, 
& Sumimoto, 2008). However, additional unknown signals might play a role in their 
complete activation (Fig.7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 7. Domain structure and regulation of formins. 
 
Several factors contribute to the release of autoinhibition established through the interaction of 
the DID and DAD domains. Active Rho GTPases such as Rho, Rac1, CDC42, or Rif trigger formin 
activity through release of autoinhibition by binding to the GBD domain. Additional signals such 
as lipidation, farnesylation, or phosphorylation have been shown to regulate activation and 
localization. Specific regulations for a formin or formin group are indicated in parentheses. 
Modified from (Katharina Grikscheit & Grosse, 2016)  
 
1.3.3 The FRL/FMNL formin subgroup in different cell processes 
 
The FRL/FMNL subgroup of formins share similar domain organization to diaphanous 
proteins (Colón-Franco, Gomez, & Billadeau, 2011) and consist of FMNL1 (FRL1), 
FMNL2 (FRL3) and FMNL3 (FRL2; here referred to as FMNL1-3 for consistency with 
recent literature). The FMNL formin family, a major focus in this thesis, is found to be co-
translationally myristoylated at the N-terminus which regulates the localization of FMNL 
formins to the plasma and intracellular membranes (Block, Breitsprecher, Kühn, et al., 
2012; Han et al., 2009; Moriya et al., 2012) and is essential for their function. N-terminal 
myristoylation also directly contributes to Golgi positioning of FMNL1γ, FMNL2, and 
FMNL3. In addition to this localization at the Golgi apparatus, both FMNL2 and 3 can be 
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found at various types of vesicles of different sizes. FMNL1γ regulates cellular F-actin 
levels required to maintain structural integrity of the Golgi complex and lysosomes 
(Colón-Franco et al., 2011), while FMNL2 and 3 can influence Golgi architecture and 
regulate anterograde transport through the Golgi apparatus (Kage, Steffen, et al., 2017). 
The formins FMNL2 and FMNL3 have been detected in filopodia as well as in 
lamellipodial structures. FMNL formin-generated filaments in lamellipodia operate in 
addition to Arp2/3 complex-dependent branching to strengthen these structures for 
promoting effective protrusion and migration (Kage, Winterhoff, et al., 2017). A critical 
role of FMNL2 in the assembly of junctional actin at newly forming cell-cell contacts in a 
3D matrix has also been described. This activity originates downstream of Rac1 and is 
in line with a physical association of FMNL2 and components of the cadherin-catenin 
complex (K Grikscheit, Frank, Wang, & Grosse, 2015). FMNL2 was further recently 
implicated in β1-integrin trafficking and reported to co-localize with the early and late 
endosomal markers Rab4/5 and Rab7, respectively (Wang et al., 2015). Moreover, 
FMNL3 was also described recently to co-localize with cytoplasmic puncta of endocytic 
origin (Gauvin, Young, & Higgs, 2015). Based on present literature, the activity of the 
FMNL2 formin is found to be regulated by the Rho GTPases Cdc42, Rac1, and RhoC 
(Block, Breitsprecher, Kühn, et al., 2012; K Grikscheit et al., 2015; Grobe, Wü, Baarlink, 
Grosse, & Grikscheit, 2018; Kitzing, Wang, Pertz, Copeland, & Grosse, 2010). 
Furthermore, protein kinase C alpha (PKC) phosphorylates the formin FMNL2 at a 
specific serine residue (Fig.8), thereby promoting its re-localization from the plasma 
membrane and activity (Wang et al., 2015). Importantly, FMNLs and mainly FMNL2 are 
upregulated in some human tumor samples and invasive cancer cell types (Péladeau, 
Heibein, Maltez, Copeland, & Copeland, 2016), making this group of formins particularly 
relevant for malignant disease. 
 
 
 
 
 
Figure 8. FMNL2 protein model showing its different domains and phosphorylation site.  
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1.3.3.1 FMNL formins in cancer 
Few studies have implicated formins in disease pathogenesis (DeWard, Eisenmann, 
Matheson, & Alberts, 2010). Through their role in cytoskeletal remodeling, uncontrolled 
formin function may be a critical event in cancer development. Formins are required for 
cytokinesis through the assembly of the contractile actin ring. Loss or deregulation of 
formin activity interferes with cytokinesis and leads to binucleate cells (Castrillon & 
Wasserman, 1994; Severson, Baillie, & Bowerman, 2002). Hence, formin activity is 
critical for proper cell division and maintenance of genomic integrity (DeWard et al., 
2010). 
Formin-like 2 (FMNL2) expression was shown to be elevated in colorectal metastatic 
cancer cell lines compared to normal colorectal cancer cell lines. In addition, FMNL2 
expression was higher in primary colorectal cancer and lymph node metastases, with 
the highest expression in the metastatic-derived cell lines (X. L. Zhu, Liang, & Ding, 
2008a). Enhanced expression is furthermore correlated with TGF-induced EMT in 
colorectal carcinoma (Yufa Li et al., 2010). Further studies identified FMNL2 as a 
potential metastasis-associated gene of CRC, where FMNL2 expression profoundly 
increases tumor growth and metastasis in vivo (X.-L. Zhu et al., 2011). Additionally, 
several microRNAs were reported to suppress growth of colon cancer through targeting 
FMNL2 (Liang et al., 2013; Yan, Wang, & Qin, 2019). In other cancer models, where 
FMNL2 and FMNL3 are filopodial components in melanoma cell lines, depletion of 
FMNL2 and/or FMNL3 led to altered cell morphology and decreased migration in vitro 
(Gardberg, Heuser, Koskivuo, Koivisto, & Carpén, 2016). Increased expression of the 
formin family member FMNL2 functioned as a significant and independent predictor of 
poor outcome as measured by recurrence-free survival or melanoma-specific survival 
(Gardberg et al., 2016). Additionally, FMNL2 was found to drive amoeboid invasion 
downstream of RhoC (Kitzing et al., 2010), where RhoC has been shown to be essential 
for metastasis (Narumiya, Tanji, & Ishizaki, 2009). FMNL2 further promotes integrin 
internalization and cancer cell invasion downstream of PKC (Wang et al., 2015). 
 
1.4 Cancer cell invasion and metastasis 
 
Most, if not all cancers have acquired the same set of functional capabilities during their 
development, albeit through various mechanisms. A key feature that distinguishes 
cancer cells from other cells is their ability to spread throughout the body by two related 
mechanisms: invasion and metastasis. These remain the most heterogeneous and 
poorly understood (Hanahan & Weinberg, 2011). 
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1.4.1 TGF induced invasion 
 
One factor that is produced abundantly by stromal cells in the tumor microenvironment 
is transforming growth factor β (TGFβ). TGFβ is a multifunctional growth factor with a 
complicated dual role in tumorigenesis (David Padua et al., 2008). TGFβ is induced in 
response to hypoxia and inflammation and can have a protective effect on tumor cells. 
However, TGFβ has also been observed to drive an epithelial-to-mesenchymal transition 
in cancer cells, which increases their metastatic capability (Welm, 2008). Since its 
discovery in the early 1980s, TGF signaling has been increasingly recognized as a key 
driver in cancer (Giannelli, Villa, & Lahn, 2014). Unlike its tumor suppressor function in 
normal tissue, TGF activation causes tumor promotion in cancer tissue. This switch 
from tumor suppression to promotion is not well clarified, but several intrinsic and 
extrinsic factors seem to play important roles (N. Sun, Taguchi, & Hanash, 2016). The 
loss of cell polarity, acquisition of motile properties, and a mesenchymal phenotype 
during epithelial-mesenchymal transition (EMT) are considered crucial intrinsic changes 
of the tumor cells (Chaffer, San Juan, Lim, & Weinberg, 2016; Wu & Zhou, 2009).  
The TGF signaling occurs via a canonical and a noncanonical pathway. The canonical 
TGF signaling pathway is activated when one of the three ligands (TGF-1, TGF-2, 
TGF-3) binds to the TGF- receptor II, heterodimerizes with the TGF--receptor I, and 
trans-phosphorylates the kinase domain of both receptors. This phosphorylation step 
leads to a recruitment and phosphorylation of SMAD2 and SMAD3. SMAD2 and SMAD3 
form a heterotrimer with the cofactor SMAD4. This complex can enter the nucleus and 
bind to regions promoting the transcription of TGF target genes. After this, a SMAD 
signaling cascade is initiated and it results in nuclear translocation and gene transcription 
for a wide range of tumor-promoting mediators (Giannelli et al., 2014). The less-known 
noncanonical activation pathway is associated with several intracellular phosphorylation 
of proteins, such as Jun N-terminal kinase (JNK), p38 MAPK, ERK, or MEKK (Derynck 
& Zhang, 2003).  
1.4.2 The EMT process 
 
The formation of a primary tumor is a multi-step process, usually through a series of 
genetic and epigenetic changes. The determining step however, is the progress of 
primary carcinoma to form invasive growth and ultimately disseminate (H. Li et al., 2016). 
This last step is referred to as the invasion-metastasis cascade. This cascade involves 
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several steps including invasion, intravasation, transport, extravasation, 
micrometastasis, and ultimately metastasis (Tsai & Yang, 2013) (Fig.9).  
 
The mechanism by which cancer cells acquire the ability to metastasize is a cell 
biological program first described in 1986, in which cells shift from one phenotypic state 
to the other (Greenburg & Hay, 1986). This is known as the epithelial to mesenchymal 
transition. This shift does not involve mutations in any genes and is hence a cell 
biological program. The  EMT process proceeds partially and cells retain epithelial 
characteristics while acquiring mesenchymal ones. The EMT endows the cells with 
increased motility, invasive potential, and anoikis resistance (Chaffer et al., 2016; Zhang 
et al., 2014). This facilitates tumor metastasis which is responsible for the vast majority 
of cancer-related deaths. EMT is a multistep process involving many molecular and 
cellular changes (Tsai & Yang, 2013). Epithelial cells are highly attached to neighboring 
cells and are poorly motile (Macara, Guyer, Richardson, Huo, & Ahmed, 2014). During 
the EMT process, we notice a loss of tight junctions and epithelial adherens junctions 
involving E-cadherin. Loss of E-cadherin, which results in the loss of cell-cell adhesion 
and cell junctions is associated with the epithelial-mesenchymal transition. This allows 
the cells to dissociate from the primary tumor, invade surrounding tissues, and migrate 
to distant sites. Cells acquire a fibroblast-like shape, resulting from the rearrangement of 
cytoskeletal protein, particularly F-actin (Lamouille, Xu, & Derynck, 2014; Xu, Lamouille, 
& Derynck, 2009).  
 
 
 
  
 
 
 
 
 
 
 
Figure 9. The EMT cascade. 
 
For tumor cells to escape from the primary site and travel to distant organs, they must become 
more motile and degrade the basement membrane. This step initiates local invasion into the 
stromal environment. We find three forms of invasion, amoeboid, mesenchymal, and collective 
migration. This leads up to intravasation into nearby blood or lymphatic vessels and travel through 
circulation. A small subset of these, now circulating tumor cells, undergo extravasation and form 
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protein (LGALS3BP)31,32,37. Cancer cell interaction with 
E-selectin seems to be important for metastasis38,39; for 
example, E-selectin ligands on prostate cancer cells are 
required for rolling on E-selectin-expressing bone mar-
row ECs in vitro and for homing to the bone marrow 
in vivo40.
E-selectin is not normally expressed on quiescent 
ECs but is induced by inflammatory cytokines, which 
can be secreted by cancer cells themselves or cancer 
cell-associated leukocytes. For example, cancer cells 
induce E-selectin expression on the liver endothelium 
around 6–8 hours after their injection in vivo, and this 
probably occurs indirectly via tumour necrosis factor-α 
(TNFα), which is secreted by tumour-recruited macro-
phages and the resident liver Kupffer cells41,42. This 
implies that E-selectin only contributes to cancer cell 
interaction with ECs after recruitment and/or activation 
of macro phages, and thus it is probably not involved 
in the initial arrest of cancer cells on the endothelium 
in vivo — at least in the liver. In the mouse lung, how-
ever, conditioned medium from cancer cells induced 
foci of E-selectin upregulation on ECs, which correlated 
with sites of cancer cell attachment in the lung 5 hours 
after cancer cell injection34. Despite this, intravital 
microscopy analysis (BOX 1) will be required to ascertain 
whether E-selectin is involved in the initial step of cancer 
cell attachment (within minutes) or whether it contrib-
utes to a later strengthening of the interaction of cancer 
cells with ECs.
Neuronal cadherin (N-cadherin; also known as cad-
herin 2) is another receptor that is involved in the roll-
ing and attachment of cancer cells on the endothelium 
in vitro (FIG. 3). N-cadherin is expressed by ECs, as well as 
by many cancer cells. This receptor promotes the rolling 
of breast carcinoma cells on ECs32. It is also important for 
the attachment of melanoma cells to ECs and for subse-
quent TEM43. However, so far there is no evidence that 
N-cadherin is involved in cancer cell attachment to ECs 
in vivo, although exogenous N-cadherin expression in 
breast cancer cells does promote their metastasis44, and 
transgenic mice that express N-cadherin in the mam-
mary epithelium had increased pulmonary metastasis in 
breast tumour models but they showed no differences in 
primary tumour onset or growth45.
Stable cancer cell–EC adhesion. In addition to the 
receptors that are involved in rolling in vitro, various 
other receptors contribute to stable cancer cell adhe-
sion to ECs, including integrins, CD44 and MUC1 
(REFS 31,46,47) (FIG. 3).
Figure 1 | Cancer cell metastatic dissemination: how cancer cells cross endothelial barriers. A small proportion of 
cancer cells from a primary tumour acquire invasive and migratory properties. Cells that leave a primary tumour invade 
their surrounding tissues using one of several types of invasion, and some of the cells will migrate towards the neighbouring 
blood vessels. Cancer cells enter the bloodstream in a process called intravasation, in which cells migrate through 
endothelial cell (EC) junctions. Using the bloodstream to spread throughout the body, cancer cells then leave the circulation 
in a process called extravasation at potential secondary tumour sites. Extravasation involves the specific interaction of 
cancer cells with vascular ECs via cell adhesion- and chemokine-related processes — during which cognate ligands or 
receptors are expressed on cancer cells and ECs — and/or the initial trapping of cancer cells within the blood vessels, owing 
to size limitation, which then leads to their specific adhesion. Cancer cells then transmigrate through the endothelial 
barrier uring a process called transendothelial m gration (TEM), and after thisthey invade the base ent membrane that 
surrounds the blood vessels. Cells can then enter a state of dormancy or proliferate within this new microenvironment, 
where a few of them will give rise to micrometastases and then macrometastases. However, most of the cancer cells that 
extravasate will not colonize these new tissues but will undergo cell death instead. ECM, extracellular matrix.
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micro-metastasis. Additional signals are required for these colonies to proliferate into macro-
metastasis. Otherwise, they remain dormant or undergo cell death. Modified from (Reymond, 
D’Água, & Ridley, 2013) 
EMT is a complex and multifaceted process that involves the coordination of many 
factors. Adding to that complexity, is the role of the microenvironment in facilitating EMT, 
as this process can be initiated by hypoxia, growth factors, and inflammation (Jing, Han, 
Zhang, Liu, & Wei, 2011). The role and function of a specific glycoprotein secreted upon 
EMT initiation, will be extensively discussed next. 
1.5 The ANGPTL4 glycoprotein 
 
ANGPTL4 was first identified in the year 2000 simultaneously by three different group (P 
Zhu, Goh, Chin, Kersten, & Tan, 2012).  It is ubiquitously expressed in humans but higher 
primarily in the liver. It is mainly involved in lipid and glucose metabolism. However, we 
now know that its function extends far beyond that with papers indicating its role in redox 
regulation, energy homeostasis, wound repair, angiogenesis, and most importantly 
tumorigenesis (P Zhu et al., 2012). 
 
1.5.1 ANGPTL4 structure and function  
 
The ANGPTL4 gene encodes a 406 amino acid glycoprotein. ANGPTL4 is composed of 
a secretory signal peptide, a coiled-coil N terminal domain and a large fibrinogen C-
terminal domain (Grootaert, Van De Wiele, Verstraete, Bracke, & Vanhoecke, 2012). 
Both domains have different biological functions. Native full-length ANGPTL4 can form 
higher order structure via intermolecular disulfide bonds. The N-terminal region 
(nANGPTL4) is responsible for its assembly into dimeric or tetrameric structures. 
ANGPTL4 protein oligomerizes prior to secretion and post-translation cleavage. The 
oligomerization is important for its ability to inhibit LPL (Lipoprotein lipase). Cleavage is 
achieved by proprotein convertases at the linker region releasing the nANGPTL4 and 
cANGPTL4 (Fig.10) (Lei et al., 2011; P Zhu et al., 2012). The cleavage appears to be 
tissue specific. Recently, the cANGPTL4 protein was shown to interact with integrins 1 
and 5 indicating a more complex role for ANGPTL4 (Goh et al., 2010). 
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Figure 10. Schematic model of ANGPTL4 indicating the cleavage site. 
 
ANGPTL4 expression is regulated by the nuclear hormone receptor of the PPAR family, 
as well as by hypoxia and fasting (P Zhu et al., 2012). TGF can also stimulate ANGPTL4 
expression via a Smad3-signaling pathway (B. Li et al., 2017). Little is known about the 
relative expression of the various ANGPTL4 fragments (FL, NT, CT) in different tissue. 
The mechanism for such tissue dependent-expression remains unclear. Much less is 
known about the expression of various ANGPTL4 fragments in tumors. However, 
elevated ANGPTL4 expression has been revealed in up to 40 known human epithelial 
tumor types where the expression increased as the tumor progressed from a benign to 
a metastatic state (Tan, Teo, Sng, Zhu, & Tan, 2012).   
 
1.5.2 ANGPTL4 in tumorigenesis and metastasis 
 
A recent study has identified ANGPTL4 as a key player in redox cancer biology where it 
confers anoikis resistance to tumors by hijacking integrin-mediated signaling to maintain 
an elevated O2-/H2O2 ratio. Additionally, ANGPTL4 knockdown enhanced cell apoptosis 
and sensitized tumor cells to drug treatment (Pengcheng Zhu et al., 2011). ANGPTL4 is 
also proposed to be a pro-angiogenic and pro-metastatic factor (Izraely et al., 2017; Le 
Jan et al., 2003). Notably, ANGPTL4 has been identified as one of the genes that can 
predict breast cancer to lung metastasis where TGF primes breast tumors for seeding 
of lung metastasis through ANGPTL4. TGF-induced ANGPTL4 enhances the retention 
of cancer cells in the lungs, disrupts vascular endothelial cell-cell junctions, increases 
the permeability of lung capillaries, and facilitates the endothelial passage of tumor cells, 
thus promoting the vital steps of metastasis (D Padua et al., 2008). Tumor-derived 
cANGPTL4 disrupts endothelial continuity by directly interacting with three novel binding 
partners: integrin 51, VE-cadherin (vascular endothelial cadherin), and claudin-5 in a 
sequential manner, thus facilitating metastasis (Huang et al., 2011). Hence, ANGPTL4 
as a diagnostic biomarker may be an important avenue to explore when considering 
future therapeutic options.  
 
 
 
 
 
 
 
  21 
2. Aim of the study 
 
In previous work, we have discovered that Formin-like 2 (FMNL2) undergoes a post-
translational modification and is phosphorylated at a specific serine residue (S1072) at 
its C-terminal Diaphanous-autoregulatory domain (DAD) which facilitates intramolecular 
autoinhibition. We identified PKC alpha as the main kinase phosphorylating FMNL2, 
thereby promoting its interaction with the alpha integrin tail as well as FMNL2 activity. 
This allows the FMNL2-integrin complex to be internalized to promote integrin recycling 
for invasive motility of cancer cells (Wang et al., 2015). In parallel, we showed that 
FMNL2 controls junctional actin dynamics in epithelial cells, where FMNL2 localizes to 
cell-cell contacts and interacts with the adherens junction complex (K Grikscheit et al., 
2015). We therefore aimed to investigate the mechanisms by which FMNL2 may switch 
its actin assembly activity between an epithelial cell-cell versus a more mesenchymal 
cell-matrix adhesion phenotype. For this we searched for phospho-FMNL2 specific 
interaction partners that could be involved in harnessing FMNL2 function for the epithelial 
to mesenchymal transition (EMT). These studies should help to identify mechanisms of 
actin regulators in promoting EMT. 
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3. Material and Methods 
 
3.1 Material 
 
3.1.1 Reagents 
 
Table 1. Reagents used. 
 
Reagent Manufacturer 
Acetic acid Roth 
ANGPTL4 (Human) protein Abnova 
Ampicillin AppliChem  
Acrylamide (30%) – bisacrylamide (0.8%) mixture  Roth 
Agar Roth 
Ammonium persulfate (APS) Merck 
ATP Sigma-Aldrich 
ASB-14 Merck 
BES Sigma-Aldrich 
Bisindolylmaleimide I Cell Signaling 
Bovine serum albumin, Fraction V  Roth 
Bromophenol blue Roth 
Calcium Chloride (CaCl2) Roth 
Chloroform Roth  
Cholera Toxin Sigma-Aldrich 
CK-666 Sigma-Aldrich 
Coomassie Brilliant Blue G250  Roth 
DAPI  Sigma-Aldrich 
DMEM (Dulbecco’s Modified Eagle’s Medium)  Capricorn 
DMEM/ F12 Gibco Life Technologies 
DNA 1 kb plus marker  Thermo Fischer  
DNA loading dye 6x Thermo Fischer  
dNTPs Promega 
DPBS (Ca
2+ 
and Mg
2+ 
free)  
PAA/GE Healthcare 
Dimethyl sulfoxide (DMSO) Roth  
Doxycycline hyclate Sigma-Aldrich 
Dry milk, fat free  Roth 
DTT (1,4-dithiothreitol) Roth 
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EDTA (ethylendiamine tetraacetic acid)  Roth 
Epidermal growth factor Promo-kinase 
Ethanol, absolute Roth 
Ethidium bromide  Roth  
FBS (fetal bovine serum) Invitrogen 
Flag (M2) -conjugated agarose Sigma-Aldrich 
Fluorescence mounting media DAKO 
Formaldehyde (37%) Roth 
Fugene HD Promega 
Glycerol Roth  
Glycine Roth 
H2O2  Sigma-Aldrich 
Horse serum Invitrogen 
Hydrochloric acid Roth 
Hydrocortisone Sigma-Aldrich 
Insulin Gibco 
Isopropanol Roth  
Kanamycin Roth 
Latrunculin  A ThermoFischer  
Lipofectamine LTX 3000 Life Technologies 
Lipofectamine RNAiMax Life Technologies 
Luminol Sigma-Aldrich 
Magnesium chloride hexahydrate  Roth 
Matrigel Corning  
2-mercaptoethanol Merck 
Methanol Roth 
OptiMEM Invitrogen 
PageRuler Prestained Protein Ladder ThermoFischer  
Penicillin/Streptomycin Capricorn 
Phalloidin, Rhodamine- /AlexaFluor- conjugated Invitrogen 
Phusion Hot Start II DNA Polymerase  ThermoFischer  
Protease inhibitor cocktail tablets, complete, 
EDTA-free 
Roche 
Protein A/G beads Santa Cruz 
Puromycin Sigma-Aldrich 
RNA-to-cDNA kit  ThermoFischer  
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SDS (sodium dodecylsulfate) Roth 
SMIFH2 Sigma-Aldrich 
Sodium chloride Roth 
Sodium dodecyl sulfate (SDS) Roth 
Sodium hydroxide  Roth 
SYBR-Green Bio-Rad 
T4 DNA Ligase  ThermoFischer 
TEMED (N,N,N',N'-tetramethyl-ethane-1,2-
diamine)  
Roth 
TPA (12-O-tetradecanoylphorbol-13-acetate)  Merck 
Tris (tris-(hydroxymethyl)-aminomethane)  Roth 
Triton X-100 Merck 
TRIzol  Invitrogen 
Trypsin-EDTA 0.05% Capricorn 
Tryptone  Roth 
Tween-20  Roth 
Yeast extract  Roth 
 
3.1.2 Antibodies 
 
Table 2. Primary antibodies used in this work. 
 
Antibody Source Manufacturer Application 
anti-ANGPTL4 rabbit 
monoclonal 
Sigma 1:1000 WB,IF 
anti-E-cadherin rabbit 
monoclonal 
CST 1:1000 WB, 1:400 
IF 
anti-N-cadherin rabbit 
monoclonal 
CST 1:1000 WB 
anti-Fibronectin mouse 
monoclonal 
Sigma 1:1000 IF 
anti-FLAG-HRP mouse 
monoclonal 
Sigma 1:5000 WB 
anti-FLAG M2 mouse 
monoclonal 
Sigma 1:250 IF 
anti-FMNL2 rabbit 
monoclonal 
Atlas antibodies, 
Stockholm  
1:2000 WB 
anti-Golgin-97 mouse 
monoclonal 
Invitrogen 1:1000 IF 
anti-GST-HRP mouse 
monoclonal 
Sigma 1:5000 WB 
anti-His rabbit 
monoclonal 
CST 1:250 WB 
anti-PKCα rabbit 
monoclonal 
CST 1:1000 WB 
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Table 3. Secondary antibodies used in this work. 
 
 
 
 
 
 
 
3.1.3 Kits 
 
Table 4. Biochemical kits used in this work. 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
3.1.4 Standard solutions and buffers 
 
Table 5. Standard solutions and buffers used.  
Solution Composition  Remarks 
2x BBS transfection 
buffer  
 
BES  
NaCl  
Na2HPO4 dissolved in 
deionized water  
0.05 M 
0.28 M  
0.0015 M  
 
pH 6.92  
 
ECL solution A Tris-HCl  
Luminol   
100 mM 
2.5 mM 
pH 8.5  
 
anti-PKC(S) rabbit 
monoclonal 
CST 1:1000 WB 
anti-Smad2/p-
Smad2 
rabbit 
monoclonal 
CST 1:1000 WB 
anti-Snail mouse 
monoclonal 
CST 1:1000 WB 
anti-Tubulin rabbit 
monoclonal 
CST 1:5000 WB 
anti-Vimentin rabbit 
monoclonal 
Abcam 1:2000 WB 
anti-rabbit IgG-
HRP 
goat Biorad 1:5000 WB 
anti-mouse IgG-
HRP 
sheep GE-Healthcare 1:5000 WB 
Kit Manufacturer 
NucleoBond Xtra Midi Plus Macherey-Nagel 
NucleoSpin gel and PCR clean-up  Macherey-Nagel 
NucleoSpin Plasmid  Macherey-Nagel 
PureLink HiPure Plasmid Macherey-Nagel 
Filter Maxiprep kit Thermo Scientific 
SuperSignal West Femto Maximum 
Sensitivity ECL Western Blotting 
Substrate 
Thermo Scientific  
Human ANGPTL4 Duoset ELISA R&D Systems 
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p-Coumaric acid   0.4 mM 
ECL solution B  
 
Tris-HCl  
H2O2  
100 mM  
0.018% 
v/v 
pH 8.5  
 
4x Laemmli buffer  
 
Glycerol  
EDTA  
SDS   
2-mercaptoethanol   
Bromophenol blue   
Tris-HCl  
28% 
10 mM 
5.7% 
4.7 mg/ml  
3.5 mg/ml  
286 mM  
pH 6.8  
 
LB agar  
 
NaCl  
Yeast extract  
Tryptone  
Agar 
dissolved in deionized 
water  
1% 
0.5% 
1% 
1.5% 
 
autoclaved  
 
LB medium NaCl 
Yeast extract 
Tryptone  
dissolved in deionized 
water  
1% 
0.5% 
1% 
 
autoclaved  
 
PBS  
 
Na2HPO4 
KH2PO4 
NaCl  
KCl 
8 mM 
1.5 mM 
137 mM 
2.7 mM 
pH 7.4  
 
PCR sample loading 
buffer (6x)  
 
Glycerol 
Bromophenol blue 
dissolved in deionised 
water  
30% 
0.25% 
 
SDS-PAGE running 
buffer  
 
Glycine 
SDS 
Tris-HCl 
192 mM  
0.1%  
25 mM  
pH 8.3  
 
SDS-PAGE stacking gel  
 
Acrylamide 
Bisacrylamide 
TEMED 
SDS 
5.9% 
0.16% 
14.5 μM 
0.1% 
pH 6.8  
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Tris-HCl 
(NH4)2S2O8 
0.12 M 
0.15% 
TAE buffer  
 
 
EDTA 
Tris  
Acetic acid 
dissolved in deionized 
water 
2 mM  
40 mM  
20 mM 
 
pH 8.0  
 
TBS-DM buffer  
 
Dry milk 
NaCl 
Tris-HCl 
Tween-20 
5% 
500 mM  
20 mM  
1%  
pH 7.5  
 
TBST buffer  
 
NaCl 
Tris-HCl 
Tween-20 
dissolved in deionized 
water 
500 mM 
20 mM 
1%  
 
pH 7.5  
 
Western blot blocking 
solution  
 
NaCl 
Tris-HCl 
Bovine serum albumin 
NaN3 
Tween-20 
 
500 mM 
20 mM  
5%  
0.1%  
1%  
pH 7.5  
 
Western blot transfer 
buffer  
 
Glycine 
Tris-HCl 
Methanol 
dissolved in deionized 
water 
192 mM 
 25 mM 
 20% v/v  
 
pH 8.5  
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3.1.5 Primers for qPCR and cloning 
 
Table 6. Primers used for qPCR. 
 
 
 
 
 
 
 
 
Table 7. Primers used for cloning. 
Gene Forward primer 5´-3´                     Reverse primer 5´-3´ 
FMNL2-
FLAG 
PLVX 
ctcgagcatgggcaacgcagggagcatgg 
 
tctagattacttgtcgtcatcgtccttgtaatccat 
ggagcccattgttatttcggcaccatt 
 
FMNL2-
(S1072A)-
FLAG 
PLVX 
ctcgagcatgggcaacgcagggagcatgg 
 
tctagattacttgtcgtcatcgtccttgtaatccat 
ggagcccattgttatttcggcaccatt 
 
ANGPTL4
-FL-
mCherry 
gtcgactcagcggtgctccgacggccggg gcggccgctcaggaggctgcctctgctgccat 
ANGPTL4
-FL-pGex 
gtcgactcggacccgtgcagtccaagtcg gcggccgctcaggaggctgcctctgctgcc
at  
ANGPTL4
-NT-pGex 
gtcgactcggacccgtgcagtccaagtcg gcggccgctcaggcaggcttggccacctca
tg 
ANGPTL4
-CT-pGex 
gtcgactcctgcccgagatggcccagccag gcggccgctcaggaggctgcctctgctgcc
at  
 
Table 8. List of Plasmids used. 
Name Details 
pMD2.G Envelope plasmid 
psSPAX2 Packaging plasmid 
pInd20 puro RFP Doxycycline inducible ctrl plasmid 
TRIPZ shANGPTL4 RFP Doxycycline inducible shANG plasmid 
pLVX-puro Lentiviral expression vector with puro resistance 
PWPXL Lentiviral constitutive gene expression 
pmCherry-N1 For mCherry protein fusion 
ANGPTL4-V5 Expression vector 
PLVX-FMNL2-FLAG Constitutive FMNL2 expression 
PLVX-FMNL2(S1072A)-
FLAG 
Constitutive FMNL2 expression 
PWPXL FMNL2-GFP Constitutive FMNL2 expression, Cloned by 
Y.Wang 
PWPXL-
FMNL2(S1072A)-GFP 
Constitutive FMNL2 expression, Cloned by 
Y.Wang 
pGEX GST gene fusion vector 
 
 
 
Gene Forward primer 5´-3´                     Reverse primer 5´-3´ 
ANGPTL4 gacccggctcacaatgtc ccctgaggctggatttca 
PRKCA acagtgtgggtggcttgtc tccttgaaaggcttaaagaaacc 
TATA-
binding 
tgcacaggagccaagagtgaa 
 
cacatcacagctccccacca 
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3.2 Constructs and cloning 
 
PCR primers were ordered from Sigma-Aldrich. Ultra-pure water was produced by water 
purification and deionization system OPTIPURE Analytic (membraPure GmbH). 
Expression constructs were generated and sequence-verified following standard cloning 
procedures. FMNL2-FLAG, FMNL2 (S1072A)-FLAG, were subcloned into the PLVX 
vector for transduction into the MCF10A cell line. ANGPTL4-V5 was purchased from 
Addgene and was subcloned into the pmCherry-N1 vector (Clonetech). Constructs of 
the different ANGPTL4 domains ANGPTL4-FL, ANGPTL4-NT, and ANGPTL4-CT were 
subcloned directly into the pGEX vector to be used for protein purification. 
 
3.2.1 Agarose gel electrophoresis  
 
DNA samples were mixed with 10x PCR sample loading buffer and loaded to 1% 
agarose gels containing 10 μg/mL ethidium bromide. DNA fragments were separated on 
the gel in TAE buffer under constant voltage in a agarose gel chamber (Bio-Rad). The 
gel was later illuminated under UV light and visualized using INFINITY gel 
documentation system (PEQLab).  
 
3.3 Cell culture 
 
3.3.1 2D and 3D cell culture 
 
HEK293T were maintained in DMEM supplemented with 10% fetal bovine serum at 37°C 
in a 5% CO2 environment. MCF10A cells were maintained in DMEM/F12 (Gibco Life 
Technologies) supplemented with 5% horse serum, 20 ng/ml epidermal growth factor, 
10 g/ml insulin, 0.5 g/ml hydrocortisone, 100 ng/ml cholera toxin, 100 U/ml penicillin, 
and 100 g/ml streptomycin at 37 °C in a 5% CO2 atmosphere as described by(Debnath, 
Muthuswamy, & Brugge, 2003). When needed, cells were treated with 4 ng/mL TGF, 
200 nM TPA, or 2 μM BIM. 
 
3.3.1 Transfection of DNA  
DNA plasmids were transfected with calcium phosphate method for HEK293T cells. 
Briefly, plasmids were mixed with autoclaved deionized distilled water. The same volume 
of 2x BBS buffer was added followed by adding 1/20 volume of 2.5 M CaCl2 dropwise. 
The transfection mixtures were incubated at room temperature for 20 min before adding 
to the cells dropwise. Cells were changed into fresh complete media after 3-4 hours. For 
transfection of MCF10A cells, Lipofectamine 3000 was used according to manufacturer’s 
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instructions. For one 6-well, plasmids were mixed in 100 μL serum free medium. 1 μL of 
Lipofectamine 3000 LTX and Plus reagent was added and mixed by vortexing. After 10 
min incubation at room temperature, transfection mixtures were added to the cells.  
3.3.2 Transfection of siRNA  
siRNAs were transfected using RNAimax following manufacturer’s instructions. For one 
6-well, 20 μM siRNA in the volume of 2 μL was mixed with 186 μL serum free media and 
4 μL RNAimax. After 10 min incubation at room temperature, the transfection mixtures 
were added to cells in a total volume of 2 mL. siRNA targeting sequences: 
si ctrl 5′-AATTCTCCGAACGTGTCACGT-3′  
si FMNL2_7 5′-TGGGACTAGATGGCCCACTAA-3′  
si ANGPTL4 5′-AUACGGAGCUACUGGUUUA-3′  
 
3.3.3 Generating stable cell lines by virus transduction  
 
MCF10A stable cell lines were generated by lentiviral transduction. Viruses were 
produced by transfecting HEK293T cells with packaging plasmid psPAX2, envelope 
plasmid pMD2G and expressing plasmids: PLVX-FMNL2-FLAG, PLVX-FMNL2 
(S1072A)-FLAG, pWPXL-FMNL2-GFP, pWPXL-FMNL2-S1072A-GFP, pGIPZ sh ctrl 
RFP, pTRIPZ sh ANGPTL4_4 RFP. sh ctrl RFP was a gift from Prof. Stiewe lab 
5′TGCTGTTGACAGTGAGCGATCTCGCTTGGGCGAGAGTAAGTAGTGAAGCCACAGATGTA
CTTACTCTCGCCCAAGCGAGAGTGCCTACTGCCTCGGA-3′. sh ANGPTL4-RFP_4 was 
purchased from Dharmacon. 1 sequence out of 4 provided a knockdown of the 
ANGPTL4 protein.  Supernatants were harvested 48 h after transfection and filtered 
through 0.45 μm filter. MCF10A cells were infected by the virus supernatant. 48 h after 
infection, cells were trypsinized and passaged. They were either FACS- sorted to 
maintain a homogeneously expressing population of cells or underwent selection with 
2.5 g/mL puromycin. To induce the expression of the desired protein, doxycycline 
(1g/mL) was added to the medium when needed. 
 
3.4 Analysis of protein expression from cultured cells  
 
3.4.1 Isolation of protein from cells  
 
Cell culture media was removed and cells were lysed by adding 200 L Laemmli buffer 
to a 6-well plate. The lysates were scraped from the cell culture dish into Eppendorf tubes 
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and incubated at 95°C for 10 min and then centrifuged for 5 min. Extracted cell lysates 
were subjected to SDS-PAGE immediately or stored at -20°C.  
 
3.4.2 SDS-PAGE and protein transfer 
 
Proteins were separated by sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) using Mini-PROTEAN Tetra Cell gel system (Bio-rad). From 8% to 12% 
separating gels were used according to the different sizes of the proteins which were to 
be separated. Gels were casted and polymerized in a vertical glass space and 
assembled into the vertical Tetra Cell chamber following manufacturer’s instructions. The 
chamber was filled with SDS running buffer. Cell lysates and standard pre-stained 
protein marker were loaded into the wells. Proteins were electrophoretically separated 
at constant voltage (80 V for stacking gel and 120 V for separating gel). The gels were 
further subjected to Coomassie blue staining or transfer.  
SDS-PAGE gels and 0.45 μm nitrocellulose membranes were assembled into a Mini 
Trans-Blot module and then into the Mini Trans-Blot Electrophoretic Transfer Cell 
following manufacturer’s instructions. The transfer cell chamber was filled with Western 
blotting transfer buffer and proteins were transferred from the gel to the membrane at 
constant voltage of 100 V for 50 min to 90 min. After the transfer, membranes were 
placed into blocking buffer and incubated for 1 h at room temperature. Different primary 
antibodies were diluted in the blocking buffer and incubated with the membranes on a 
shaker for 1 to 2 h at room temperature or overnight at 4°C. Membranes were washed 
10 min each for three times with TBST  and incubated with secondary antibodies in 
blocking buffer for 1 h at room temperature when necessary. Membranes were washed 
again 10 min each for three times with TBST before developing. Enhanced 
chemiluminescence was used to detect the horseradish peroxidase-conjugated 
antibodies. Films (Fuji) were exposed on top of the membrane with ECL at different time 
points in a dark room and developed with the developing machine. The primary and 
secondary antibody dilutions are listed in Table 8.  
 
3.4.3 RNA isolation and CDNA reverse transcription 
 
1 mL of cold TRIzol reagent was added to the cells, they were then scraped and 
transferred to Eppendorf tubes. 200 L of chloroform was added before vortexing. The 
samples were then centrifuged for 15 min at 12000 rpm at 4°C. The transparent phase 
was transferred to a new Eppendorf tube. 500 L of Isopropanol was added. After 10 
min, tubes were centrifuged again for another 10 min at 12000 rpm. One final washing 
step was done with 1 mL of Ethanol and then the RNA was left to dry. 
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1 g RNA was mixed with 1 L of 100 M random hexamers and heated at 65°C for 5 
min following 5 min of cooling on ice for another 5 min. A reaction mixture consisting of 
1 L reverse transcriptase, 1x RT buffer, 2 L of 10 mM dNTP mix, 1 L RNAse inhibitor 
with additional water to get a total volume of 19 L was then then added to the 
RNA/primer mixture and mixed. Reaction was run as the following, 
10 min 25°C, 60 min 42°C, 10 min 70°C.  
 
3.4.4 qPCR 
 
cDNA was diluted 1:5 ,primers were designed by the online tool Universal Probe library 
and listed in Table 6. A 20 μl PCR reaction mixture was composed from 12.5 μl SYBR 
Green Mix (2x) 7 μl H2O and 0.5 μl primers in a mix (1:1). PCR was run in a 96-well 
Real-Time Quantitative Thermal Cycler (Biorad) under the following program: 
Time Temperature 
3 min 95°C 
10 sec 95°C 
30 sec 60°C                     40 cycles 
30 sec 72°C 
2 min 95°C 
30 sec 55°C 
 
3.4.5 ELISA 
 
ELISA assay was performed according to the manufacturer's instructions (BioRad). 
Shortly, the supernatant was harvested after different treatments and diluted 1:10 and 
1:40. The plate was treated with capture antibody, blocked, samples added, detection 
antibody, streptavidin-HRP, substrate solution. Washing was done 3x between each step 
except after the last one. The reaction was stopped and absorbance was read at 450 nm 
in the plate reader. 
 
3.4.6 Mass spectrometry 
 
Mass spectrometry was performed in the Max Planck institute in Bad Nauheim as a 
collaboration between our lab and Dr. Johannes Graumann. Briefly, immunoprecipitation 
of different cellular lysates was perfomed (3.5), and after the last washing step, samples 
were snap-frozen and sent for analysis.  
 
3.5 Immunoprecipitation  
 
Cells were harvested 24 or 48 h after stimulation with TGF by scraping and lysed in 
lysis buffer containing 20 mM Tris-HCl (pH 7.4), 150 mM NaCl, 2 mM EDTA, 0.1% ASB-
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14, and complete protease and phosphatase inhibitors. Supernatants were collected 
after centrifugation (20,000 rpm, 15 min at 4°C) and incubated with FLAG conjugated 
agarose beads (Sigma) or Protein A/G beads for 90 min at 4°C. Beads were centrifuged 
and washed four times with lysis buffer. 2x Laemmli buffer  was added and samples were 
subjected to SDS-PAGE gel and Western blotting.  
 
3.6 Protein purification 
The expression plasmid was transformed into E. coli BL21 (DE3). Bacteria were cultured 
in LB medium at 37°C until OD=0.6 and induced with 200 μM IPTG at 22°C for 16 h. 
GST fusion protein was purified using Glutathione Sepharose 4B beads (GE Healthcare) 
as described before (Brandt et al., 2007). Briefly, bacteria were harvested by 
centrifugation and lysed by sonication in lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM 
NaCl, complete protease inhibitors). After centrifugation at 13,000 rpm at 4°C for 45 min, 
supernatant was collected and loaded to pre-equilibrated Glutathione Sepharose 4B 
beads. Beads were washed three times with high-salt washing buffer (50 mM Tris-HCl 
pH 8.0, 500 mM NaCl) and three times with non-salt washing buffer (50 mM Tris-HCl pH 
8.0) subsequently before eluting with elution buffer (50 mM Tris-HCl pH 8.0, 10 mM 
Glutathione reduced).  
6xHis fusion protein was purified using Ni-NTA agarose beads (Qiagen). Bacteria were 
lysed in 1×PBS pH 7.4, 30 mM Imidazole and 1% NP-40 with complete protease 
inhibitors. After centrifugation, supernatant was collected and loaded to pre-equilibrated 
Ni-NTA beads followed by three times high salt washing (1×PBS pH 7.4, 20 mM 
Imidazole, 350 mM NaCl) and three times low salt washing (1×PBS pH 7.4, 20 mM 
Imidazole). 6xHis fusion proteins were eluted in fractions with elution buffer (1×PBS pH 
7.4, 350 mM Imidazole). Fractions were loaded to SDS-PAGE gels and subjected to 
Coomassie blue staining to visualize the proteins of interests. Fractions with desired 
protein were pooled and concentrated when needed. 
3.7 Immunofluorescence staining and confocal microscopy 
 
MCF10A cells were seeded on glass bottom dishes. 24 h or 48 h after 
transfection/transduction, cells were washed with PBS and fixed with 8% formaldehyde 
for 10 min at room temperature. After washing with PBS, 0.02% Triton-X 100 in PBS was 
used to permeabilize the cells for 10 min. Cells were blocked with 5% BSA in PBS for 1 
h at room temperature. Primary and secondary antibodies were diluted in the blocking 
solution and incubated with the coverslips for 1 h each with three times PBS washing 
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between the two steps. DAPI staining was performed for 10 min when indicated. 
Coverslips were then mounted on the glass slides using fluorescent mounting media.  
 
3.8 Live cell imaging  
 
MCF10A cells were seeded on glass bottom dishes. 24 h or 48 h after transfection, live 
cell imaging was performed at 37°C, in a CO2 chamber. Images were acquired every 30 
sec with a Spinning disk confocal microscope (Zeiss), using the 100×/1.4 oil objective. 
Drugs were applied to the cells directly at the microscope while scanning. Images were 
later processed with Image J software or Metamorph.  
 
3.9 Invasion assays and image analysis  
 
Inverted Transwell invasion assays were performed as described (Kitzing et al., 2010). 
Cells were seeded 48 h before the assay and stimulated with TGF. Upper chambers of 
the Transwell inserts were coated with 50 μL growth factor reduced Matrigel (BD 
Biosciences) and polymerized for 60 min at 37°C. The inserts were inverted allowing cell 
seeding (10,000 cells per inserts for MCF10A cells) and adhering on the outer bottom. 
After 1 h, the Transwell inserts were reverted. The upper chambers were filled with 
medium containing or void of TGF based on the condition studied. Cells were allowed 
to invade for 48 h before fixation, permeabilization and subsequent staining with DAPI 
and phalloidin 488. Confocal z-stacks of 100 μm were acquired every 5 μm for nine 
random imaging fields of each insert with LSM 700 confocal microscope (Zeiss), using 
the 40X objective and the ZEN software (Zeiss). Quantification of the invaded (more than 
15 μm) and non-invaded cell number was achieved using the Image J Analyze Particle 
function counting the number of the nucleus. Doxycycline was added to induce the 
expression of certain genes when needed. 
 
3.10 Statistical analysis 
 
Fluorescent image processing was done using ImageJ or Metamorph. PRISM was used 
for all statistical tests performed. 
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4. Results 
 
The re-localization of FMNL2 away from the plasma membrane after phosphorylation by 
PKC (Wang et al., 2015) appears to be reminiscent of the loss or dissociation of 
membrane proteins, occurring during the epithelial to mesenchymal transition. Taken 
into consideration the critical role FMNL2 plays in cell-cell adhesion formation (K 
Grikscheit et al., 2015; Grobe et al., 2018), we further aimed to understand its function 
in the cell-matrix context. 
We chose the immortalized but non-transformed MCF10A breast epithelial cell line. 
MCF10A cell lines express a relatively high level of FMNL2 relative to other present 
formins (K Grikscheit et al., 2015) and are commonly used to study the epithelial to 
mesenchymal transition. Through the addition of TGF to the cellular medium, EMT is 
induced in various epithelial cell lines. As previously published (Zhang et al., 2014), 4 
ng/mL of hTGF1 solution was sufficient to successfully induce EMT in the MCF10A cell 
line.  
 
4.1 TGF-induced epithelial to mesenchymal transition in MCF10A cells 
 
To determine whether stimulation with 4 ng/mL of TGF solution is effective, we tested 
this concentration in 2D and 3D cell culture accordingly. We could notice a drastic 
alteration in cellular morphology following exposure to TGF. Microscopic examination 
revealed that the untreated cells display the cuboidal appearance characteristic of 
epithelial cells in 2D culture. The untreated cells in 3D culture also maintained the typical 
acini structure known for epithelial cells grown in Matrigel over time. Exposure to TGF 
in 2D induced a phenotypic change where cells appeared elongated and spindle-like 
displaying abundant actin stress fibers. Whereas in 3D, the acini structures were lost and 
replaced by a flat spread out structure (Fig.11). The phenotypic change in the 
differentiation state was evident within 24-48 hr.  
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Figure 11. TGF stimulation of MCF10A cells in 2D and 3D cell culture. 
 
2D culture: MCF10A cells were cultured for 48 hr in the presence or absence of 4 ng/mL of TGF 
then fixed and stained with phalloidin and DAPI. 3D culture: MCF10A cells were seeded in 
Matrigel and cultured for 10 days. TGF was added to the medium on the last two days. Cells 
were then fixed and stained with phalloidin and DAPI. Scale bar, 15 m. 
 
To verify the induction of the epithelial to mesenchymal differentiation in these epithelial 
cells, we tested whether the change in morphology correlated with the disappearance of 
epithelial markers and appearance of mesenchymal markers. We examined the 
expression of E-cadherin and the characteristic pattern of actin fibers using 
immunofluorescence. Over the time course of five days, we could see a decrease in the 
intensity of the E-cadherin staining, mainly at the cell-cell contact areas. We also 
observed the remodeling of actin filaments from cortical rings to abundant ventral stress 
fibers (Fig.12A). On the transcriptional program level, we saw an upregulation of the 
typical N-cadherin, Vimentin, and Snail markers, and a downregulation of E-cadherin 
(Fig.12B).  
 
 
  37 
4.1.1 TGF-induced epithelial mesenchymal transition in MCF10A WT cells. 
 
Figure 12. TGF-induced epithelial mesenchymal transition in MCF10A WT cells. 
 
(A) MCF10A cells were stained for E-cadherin and actin before and after TGF stimulation (48 
hr, 120 hr) to visualize cytoskeletal and cell-cell contact changes accompanying EMT. Scale bar, 
20 m. (B) MCF10A cells were stimulated with TGF (4 ng/mL) and samples were collected every 
24 hr. Lysates were blotted against known EMT markers.  
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4.1.2 TGF-induced epithelial mesenchymal transition in MCF10A FMNL2 KO 
cells. 
 
To check if FMNL2 activity is necessary for EMT induction on the transcriptional level, 
we utilized the MCF10A FMNL2 KO cell line. Cells were stimulated with TGF, fixed and 
stained (Fig.13A). The lysates were blotted against the previously used EMT markers 
(Fig.13B). We observe the same trend as with the MCF10A WT cells and conclude that 
FMNL2 KO cells undergo EMT as well. 
To test whether the proximal step of TGF signaling was affected in the knockout cell 
line we probed for phosphorylated Smad2 and total Smad. Phosphorylated Smad2, an 
initial effector of the activated TGF receptor, forms a complex with other Smad proteins 
and translocates to the nucleus to complex with transcription regulators repressing or 
activating target genes such as E-cadherin and Snail (Lamouille et al., 2014). We could 
notice the expected gradual increase in p-Smad2 following the addition of TGF in both 
WT and knockout cell lines. Total Smad was unchanged in the absence or presence of 
TGF (Fig.13C). Hence, the initial transcriptional EMT program is not affected upon 
FMNL2 knockout. 
 
4.2 TGF-induced PKC upregulation in MCF10A cells 
 
Previous experiments to study the role of PKCs in FMNL2 regulation were performed in 
HeLa cells which express a high level of PKC, the major kinase responsible for FMNL2 
phosphorylation. The phorbol ester TPA (12-O-Tetradecanoylphorbol-13-acetate) was 
used as a stimulant to induce the phosphorylation of FMNL2 and further downstream 
effects. TPA activates PKC by binding to its regulatory domain (Steinberg, 2008). 
 
We compared HeLa and MCF10A lysates after stimulation with 200 nM of TPA for 20 
min and could observe that MCF10A cells only express a traceable amount of PKC. 
However, we could still notice an increase in expression of PKC upon stimulation with 
TPA (Fig.14A). To validate if TGF leads to the same effect, we stimulated MCF10A 
cells with 4 ng/mL TGF for 24 and 48 hours and could indeed see an increase in protein 
expression (Fig.14B). This was quantified by measuring band intensity relative to tubulin 
(Fig.14C) and validated through qPCR (Fig.14D). 
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Figure 13. TGF-induced epithelial mesenchymal transition in MCF10A FMNL2 KO cells. 
(A) MCF10A cells were stained for E-cadherin and actin before and after TGF stimulation (48 
hr, 120 hr) to visualize cytoskeletal and cell-cell contact changes accompanying EMT. Scale bar, 
20 m. (B) MCF10A cells were stimulated with TGF (4 ng/mL) and samples were collected every 
24 hr. Lysates were blotted against known EMT markers. (C) Immunoblots of lysates from 
MCF10A WT and MCF10A FMNL2 KO cells maintained for different times in the absence or 
presence of TGF (4 ng/mL), probed for phosphorylated Smad2 (pSmad2) and total Smad2.  
 
Figure 14. TGF-induced PKC upregulation in MCF10A WT cells. 
 
(A) Lysates from TPA (200 nM) stimulated HeLa and MCF10A cells were collected and 
compared for PKC expression. (B) Lysates from TGF stimulated and non-stimulated 
MCF10A WT cells (24 hr, 48 hr) were collected and analyzed for PKC expression followed by 
band intensity quantification in (C) (ratio of PKC/tubulin). (D) Relative PKC mRNA levels after 
TGF stimulation of MCF10A cells (24 hr, 48 hr). Data is expressed as mean ± SEM. n=2. 
Student’s t-test was performed for statistical analysis in (C) & (D)*p< 0.05. 
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4.3 TGF-induced FMNL2 phosphorylation downstream of PKC 
 
Next, we aimed to check if TGF stimulation also results in the phosphorylation of 
FMNL2 at the aforementioned serine residue (S1072A). To guarantee a rapid and 
efficient immunoprecipitation of FMNL2 from MCF10A cells, all required FMNL2 
constructs were cloned with a C-terminal FLAG tag to avoid any mis-localization issues 
since N-terminal myristoylation is required for proper localization of FMNLs (Moriya et 
al., 2012). They were then transduced into the MCF10A FMNL2 KO cell line. The 
constructs were checked for proper expression and localization (Fig.15A).   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 15. TGF promotes PKC-dependent phosphorylation of FMNL2. 
 
(A) MCF10A cells were transduced with FMNL2-FLAG construct and the proper expression and 
localization was verified by an anti-FLAG immunoblot and immunofluorescent staining. Scale bar, 
20 m. (B) Immunoprecipitation of MCF10A FMNL2 KO cell lysates stably expressing FMNL2-
FLAG at different timepoints after stimulation with 4 ng/mL TGF. An antibody specifically 
recognizing phospho-(Ser) PKC substrate was used to detect phosphorylated FMNL2. (C) 
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Immunoprecipitation of MCF10A FMNL2 KO cell lysates stably expressing FMNL2-FLAG after 
stimulation with 4 ng/mL TGF, 200 nM TPA, or 2 M BIM respectively. 
 
Following TGF stimulation, FMNL2 could be phosphorylated with a rapid increase. The 
phosphorylation event was evident within 10 min, level decreased shortly, then 
recovered after 2 hr (Fig.15B). Phosphorylation could also be detected at later timepoints 
(24, 48, and 72 hr, data not shown). Importantly, phosphorylation was diminished upon 
BIM (bisindolylmaleimide) treatment (Fig.15C) identical to the effect seen with TPA + 
BIM. This indicates the involvement of PKCs in phosphorylating FMNL2 downstream of 
TGF, since BIM acts as an ATP competitive inhibitor and binds the kinase domain of 
PKCs (Grodsky et al., 2006). 
 
4.4 Functional analysis of FMNL2 and ANGPTL4  
 
4.4.1 ANGPTL4 as a novel TGF-induced FMNL2 interaction partner 
 
To search for additional factors involved in this pathway, we used mass spectrometry to 
identify FMNL2 interaction partners during TGF-induced EMT. We immunoprecipitated 
FMNL2-FLAG with or without TGF stimulation and the samples were sent for analysis. 
We observed a single significant hit, the matricellular protein Angiopoietin-like 4 
(henceforth ANGPTL4) (Fig.16A). The result was confirmed by immunoprecipitating 
FMNL2-FLAG and blotting against endogenous ANGPTL4. Noticeably, the non-
phosphorylatable mutant of FMNL2 did not interact with endogenous ANGPTL4 
(Fig16.B). Hence, we conclude that the phosphorylation of FMNL2 is required for its 
interaction with ANGPTL4. A point mutation of the Ser residue into Ala (S1072A) to 
destroy the phosphorylation was introduced. The mutant S1072A could not be detected 
by the phospho-Ser antibody in all treatments (Wang et al., 2015).  
To determine the existence of a direct interaction between FMNL2 and ANGPTL4, we 
purified the NT and CT of FMNL2 in addition to ANGPTL4-FL, NT, and CT.  Based on 
the GST-pulldown results, we could detect a direct interaction between ANGPTL4-FL 
and both the NT and CT of FMNL2, while only ANGPTL4-NT showed this interaction 
(Fig.16C). We questioned the whereabouts of this interaction and used two different 
predictive tools (TMpred,TMHMM), to determine the exact structure of the ANGPTL4 
protein (Fig.17 A,B). Both tools predicted a transmembrane domain in the N-terminus of 
ANGPTL4 between amino acid residues 17 and 33 following the signal peptide. Hence, 
it is feasible to assume that the interaction between FMNL2 and ANGPTL4 could be at 
cellular membranes.  
 
  43 
 
Figure 16. TGF-induced interaction of FMNL2 with ANGPTL4. 
(A) Mass spectrometry was performed after FLAG immunoprecipitation to determine possible 
interaction partners of FMNL2 (ctrl v.s. TGF stimulation). The volcano plot summarizes the 
differential expression analysis. The strongest candidate is labeled. (B) Immunoprecipitation of 
MCF10A FMNL2 KO cells stably expressing FMNL2-FLAG or FMNL2 (S1072A)-FLAG 
with/without TGF stimulation (4 ng/mL) for 48 hr. Endogenous ANGPTL4 is detected. (C) GST-
pulldown assay showcasing the interaction between GST tagged ANGPTL4 domain (FL,NT,CT) 
and His tagged FMNL2 (NT,CT). 
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4.4.2 ANGPTL4 domain organization 
 
Figure 17. Schematic representation of the ANGPTL4 protein and its putative transmembrane 
domain. 
 
(A) Full length ANGPTL4 and the three different constructs used for protein purification. (B) 
Probability plot for a predicted transmembrane region in ANGPTL4 by TMHMM software. 
 
 
4.4.3 ANGPTL4 secretion requires FMNL2 
 
ANGPTL4 is secreted in response to TGF stimulation (D Padua et al., 2008). We next 
determined its secretion level using an ELISA assay. We compared ANGPTL4 
concentration in the presence and absence of TGF stimulation (24 hr /48 hr) and 
whether the knockout or modification of FMNL2 had an effect on its secretion. Depicted 
are the ELISA results after 48 hr of stimulation (Fig.18A). 
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The results reflect that ANGPTL4 is secreted in high concentrations reaching 600 ng/mL 
after TGF stimulation for 48 hr. Knockout of FMNL2 significantly reduces the secreted 
concentration to around 160 ng/mL. While re-introducing FMNL2-FLAG in the knockout 
cell line managed to rescue the secretion levels back to 500 ng/mL, re-introducing the 
phospho-mutant showed a similar result to the knockout cell line with low levels around 
150 ng/mL. Without TGF stimulation, ANGPTL4 secretion appeared to be stagnant with 
minimal levels ranging around 50 ng/mL (Fig.18A). The cellular lysates were blotted 
against ANGPTL4 and a loading control (Fig.18B). 
 
Figure 18. TGFβ targets FMNL2 for ANGPTL4 secretion. 
 
(A) MCF10A cell lines were treated with TGFβ for 48 hr followed by supernatant collection and 
an ELISA assay to determine ANGPTL4 concentration. (B) The cellular lysates were also 
collected and blotted against ANGPTL4 and tubulin as a loading control. (C) MCF10A WT cells 
were pre-treated with TGFβ for 24 hr followed by 48 hr of the respective inhibitor treatment and 
an ELISA assay. Working concentrations: Latrunculin B: 500 nM, SMIFH2: 10 μM, CK666: 25 
mM, BIM: 2 mM. (D) The cellular lysates were collected and blotted against ANGPTL4 and tubulin 
as a loading control. n=4, One-way ANOVA was performed to determine significance.*p<0.05 
***p<0.001. 
 
 
Next, we tested different inhibitors acting on G-actin (Latrunculin), Formins (SMIFH2), 
Arp2/3 complex (CK-666), or PKC (BIM) to see their influence on ANGPTL4 secretion. 
Cells were first stimulated for 24 hr with TGF to initiate the transition and then the 
different indicated inhibitors were added for 48 hr, followed by supernatant collection. 
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Adding TGF and the inhibitors simultaneously had no effect (data not shown). We saw 
a minor but no significant decrease with Latrunculin, SMIFH2, and BIM (Fig.18C). The 
cellular lysates were blotted against ANGPTL4 and a loading control (Fig.18D). 
 
4.5 Subcellular localization of FMNL2 and ANGPTL4 in MCF10A cells  
 
To understand the relationship of FMNL2 and ANGPTL4 with intracellular structures and 
the possible cellular functions, we visualized ANGPTL4 on Fibronectin or in the Golgi 
apparatus after TGF stimulation (Fig.19A). ANGPTL4 still present in the Golgi, is 
considered to be non-secreted while secreted ANGPTL4 localizes on Fibronectin in the 
extracellular matrix.  
 
4.5.1 Fixed-cell imaging of FMNL2 and ANGPTL4 in MCF10A cells  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 19. TGF-induced FMNL2 and ANGPTL4 localization in cellular structures . 
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(A) Extracellular (secreted) ANGPTL4 was stained and compared to intracellular (non-secreted) 
ANGPTL4 present in the Golgi after 48 hr of TGF stimulation (4 ng/mL). The differences between 
the three different WT, FMNL2 KO, and FMNL2 (S1072A) cell lines were assessed. Scale 
bar,10m. (B) % of fluorescence in (A) was quantified and evaluated between the three different 
cell lines by Dr. Carsten Schwan. One-way ANOVA was performed to determine significance. **p 
<0.01 ***p <0.001. (C) High resolution microscopy visualizing secreted ANGPTL4 on Fibronectin. 
The three lower images represent zoom ins of the three respective drawn boxes. 
 
We compared the differences in secretion between the WT, KO, and phospho-mutant 
expressing cell lines. From comparing % of fluorescence, we find less secreted 
ANGPTL4 (outside the Golgi) in the KO and S1072A cell lines (Fig.19B). We also notice 
more ANGPTL4 sequestered in the Golgi in the KO and S1072A cell lines. This indicates 
a possible secretion disadvantage due to the loss of functional phosphorylated FMNL2. 
This further confirms our previous ELISA results and that FMNL2 is required for 
ANGPTL4 secretion following TGF stimulation. To pinpoint the position of secreted 
ANGPTL4 in the extracellular matrix after TGF stimulation, we utilized high resolution 
microscopy and stained both ANGPTL4 and fibronectin. ANGPTL4 decorated fibronectin 
at cell edges, and was distributed in the extracellular matrix (Fig.19C).  
 
4.5.2 Live-cell imaging of FMNL2 and ANGPTL4 in MCF10A cells  
 
Finally, ANGPTL4-mCherry was transfected in the MCF10A FMNL2-GFP cell line for the 
live visualization of this process. Cells were stimulated with a higher dose of TGF (40 
ng/mL) and then imaged on the next day to monitor any co-localization events occurring 
between FMNL2 and ANGPTL4 (Fig.20A). We could successfully observe a transient 
localization of FMNL2 with ANGPTL4 at certain timepoints indicated with arrows (Fig. 
20B).   
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Figure 20. TGFβ-induced FMNL2 and ANGPTL4 co-localization. 
 
(A) MCF10A-FMNL2-GFP cells were transfected with ANGPTL4-mCherry and stimulated with 40 
ng/mL TGFβ on the next day. Cells were imaged after 24 hr of stimulation using spinning disk 
confocal microscopy to monitor FMNL2 and ANGPTL4 trafficking. Scale bar,10m. (B) Zoom ins 
of two different regions pinpointing FMNL2 and ANGPTL4 co-localization. 
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4.6 FMNL2 and ANGPTL4 determine cell-cell contact integrity 
4.6.1 Knockdown of ANGPTL4 in MCF10A WT cells 
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Figure 21. TGFβ-induced cell-cell contact changes in MCF10A WT cells. 
 
(A) siRNA targeting ANGPTL4 or FMNL2 was transfected in MCF10A cells and the expression 
of both proteins was compared using immunoblotting. Scale bar, 20 m (B) Cells were stimulated 
with TGFβ for 48 hr after siRNA transfection. They were further fixed and stained against E-
cadherin and actin to visualize cell-cell contact integrity. (C) Quantification of the cell-cell contact 
area and length/perimeter. The white boxes serve as examples of the measured areas. Data is 
expressed as mean ± SEM, n ≤ 40. One-way ANOVA was performed to assess the 
significance.**p< 0.01, ***p< 0.001. 
 
To monitor if the knockdown of ANGPTL4 had an effect on FMNL2 expression and vice 
versa, the proteins were silenced separately (Fig.21A). Reduction of ANGPTL4 had no 
effect on FMNL2 expression. However, we could observe less ANGPTL4 with FMNL2 
knockdown. This is in line with our previous results which indicate a role of FMNL2 in 
ANGPTL4 secretion and hence in the availability of the protein inside the cells. ANGPTL4 
was previously reported to disrupt cell-cell contacts and facilitate lung metastasis in mice 
(Huang et al., 2011). To more closely observe cell-cell contact changes influenced by 
ANGPTL4 in our model, we silenced the latter in MCF10A WT cells then stimulated for 
48 hr with TGF (4 ng/mL). Cells were fixed and stained against E-cadherin and actin 
(Fig.21B). We chose to quantify cell-cell contact area and length/perimeter. Area showed 
an increase after TGF stimulation in the control and ANGPTL4 knockdown but to a 
lesser extent in the case of the knockdown. Length/Perimeter decreased accordingly in 
both cases (Fig.21C). An increase in cell-cell contact area indicates the disruption of the 
rigid and tight cell-cell contacts, leading to cell spreading and further migration. A 
decrease in length/perimeter signifies the disassembly of epithelial junctions and loss of 
the continuous cell boundaries. The FMNL2 KO cell line showed a modest increase in 
cell-cell contact area following TGF stimulation, around 60 m2, albeit lesser than the 
increase seen in the WT (80 m2).  Upon ANGPTL4 silencing, we observed a 
pronounced decrease in cell-cell contact area reaching 30 m2 (Fig.22B) .  
Length/perimeter decreased in the knockout cell line after TGF stimulation, but this 
decrease was reversed upon ANGPTL4 silencing to rise back to 0.25. We conclude, that 
the combined loss of both FMNL2 and ANGPTL4 yields a much more prominent 
phenotype indicating a dual role of these two proteins in modulating cell-cell contact 
integrity during TGF-induced EMT.  
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4.6.2 Knockdown of ANGPTL4 in MCF10A FMNL2 KO cells 
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Figure 22. TGFβ-induced cell-cell contact changes in MCF10A FMNL2 KO cells.   
 
(A) Cells were stimulated with TGFβ for 48 hr after siRNA transfection. They were further fixed 
and stained against E-cadherin and actin to visualize cell-cell contacts. Scale bar, 20 m (B) 
Quantification of the cell-cell contact area and length/perimeter. The white boxes serve as 
examples of the measured areas. Zoom ins are displayed to the right. Data is expressed as mean 
± SEM, n≤ 40. One-way ANOVA was performed to assess the significance.*p< 0.05,**p< 0.01, 
***p< 0.001. 
 
To monitor if the addition of ANGPTL4 could augment or rescue our phenotype, 1g of 
recombinant ANGPTL4 protein was added to the cells along with TGF stimulation. We 
could observe a gain in the cell-cell contact area of the WT cells (Fig.23A,B) and a more 
pronounced difference in the length/perimeter parameter (ctrl vs. TGF +ANGPTL4). 
Hence, addition of exogenous ANGPTL4 aids in the disintegration of cell-cell contacts. 
Noticeably, the rescue effect in the FMNL2 KO cell line was evident. Upon addition of 
the ANGPTL4 protein, the cell-cell contact area proceeded to increase (90 m2) 
indicating disruption of the cell-cell contacts and spreading. Length/perimeter decreased 
accordingly from 0.3 to 0.15 upon TGF + ANGPTL4 protein addition (Fig.24 A,B). We 
infer that ANGPTL4 can rescue the FMNL2 knockout effect and drive EMT execution.  
 
4.7 TGF-induced invasion requires both FMNL2 and ANGPTL4 
 
Finally, to determine a dual role for ANGPTL4 and FMNL2 in tumorigenesis, we  
performed 3D inverted invasion assays. We transduced MCF10A FMNL2 cell lines with 
sh ctrl or sh ANGPTL4. The expression of the sh RNAs was induced with doxycycline 
and inverted invasion assays were performed. MCF10A WT cells showed a modest 
increase in invasion capacity after the 4-day stimulation with TGF reaching 8%. 
However, when FMNL2 was overexpressed, this increased to 37%. FMNL2 KO cell lines 
showed almost no invasion (1%), but this effect could be rescued when FMNL2 was re-
introduced in the system (30%) but not by re-introducing the phospho-mutant (5%) (Fig. 
25B). The invasion capacity of the WT and WT-FMNL2 cell lines was further reduced 
with the knockdown of ANGPTL4 (Fig.25C). However, invasion capacity of the FMNL2 
KO cell line could not be rescued with the addition of the ANGPTL4 recombinant protein 
(Fig.25E). % invasion represents the number of cells which crossed the Matrigel barrier 
over the total number present on the bottom of the Matrigel. We conclude that TGF-
induced invasion requires both FMNL2 and ANGPTL4. 
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4.6.3 Addition of ANGPTL4 in MCF10A WT cells 
 
Figure 23. Influence of ANGPTL4 on TGFβ-induced cell-cell contact changes in MCF10A WT 
cells. 
 
(A) WT cells were stimulated -/+TGFβ for 48 hr, along with the addition of 1 g recombinant 
ANGPTL4. They were further fixed and stained against E-cadherin and actin to visualize cell-cell 
contacts. Scale bar, 20 m (B) Quantification of the cell-cell contact area and length/perimeter. 
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The white boxes in (A) serve as examples of the measured areas. Data is expressed as mean ± 
SEM, n ≤ 40. One-way ANOVA was performed to assess the significance.**p< 0.01,***p< 0.001. 
4.6.4 Addition of ANGPTL4 in MCF10A FMNL2 KO cells 
 
Figure 24. Influence of ANGPTL4 on TGFβ-induced cell-cell contact changes in MCF10A KO 
cells. 
(A) KO cells were stimulated -/+TGFβ for 48 hr, along with the addition of 1 g recombinant 
ANGPTL4. They were further fixed and stained against E-cadherin and actin to visualize cell-cell 
contacts. Scale bar, 20 m (B) Quantification of the cell-cell contact area and length/perimeter. 
The white boxes in (A) serve as examples of the measured areas. Data is expressed as mean ± 
SEM, n ≤ 40. One-way ANOVA was performed to assess the significance.*p< 0.5,***p< 0.001. 
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Figure 25. TGFβ-dependent invasion requires FMNL2 in addition to ANGPTL4.   
(A) Experimental setup of the 3D inverted invasion assay. Cells were treated with doxycycline (1 
mg/mL) a day before the start of the experiment to induce the expression of shRNAs. The cells 
were stimulated with TGF for 48 hr (1) then plated upside down on a Matrigel-coated thincert 
(2,3). After incubation to allow cells to adhere, the thincert was placed in TGF containing medium 
(4) and the cells were allowed to invade for 48 hr through the Matrigel (5). They were then fixed 
and stained for DAPI to image invaded vs. non-invaded cells (6). (B) Different cell lines expressing 
sh ctrl were subjected to a 3D inverted invasion assay using Thincerts. % invasion is shown.  Data 
is expressed as mean ± SEM, n=3. One-way ANOVA was performed to assess the 
significance.**p< 0.01,***p< 0.001.  (C) sh ANGPTL4 was induced in the WT and most invasive 
cell line, WT (FMNL2-GFP) prior to the invasion assay. % Invasion is shown. Data is expressed 
as mean ± SEM, n=2. Student’s t-test was performed to assess the significance.*p< 0.05. (D) 
Immunoblots confirming the efficiency of the shRNA in both WT and WT (+FMNL2) cell lines. (E) 
Recombinant ANGPTL4 protein (1 g) was added to the Matrigel before beginning the assay. % 
Invasion is shown. Data is expressed as mean ± SEM, n=2. Student’s t-test was performed to 
assess the significance. n.s. no significance. 
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5. Discussion 
 
5.1 Role of the actin regulator, FMNL2, in the transcriptional program of the EMT 
process 
Although the transcriptional program for EMT is well characterized and known to be 
coordinated primarily through activation of transcription factors such as Snail, ZEB, and 
Twist that repress expression of epithelial genes and activate expression of 
mesenchymal genes (Xu et al., 2009), less is known about how the morphological 
program of EMT is controlled and whether it also regulates transcriptional events. 
Cytoskeletal remodeling during EMT depends on changes in the expression of actin 
regulatory proteins, such as moesin (Haynes, Srivastava, Madson, Wittmann, & Barber, 
2011), zyxin (Mori et al., 2009), and most importantly the formins (Jurmeister et al., 2012; 
Y. Y. Li, Jiang, Chen, Jiang, & Jiao, 2019; Yufa Li et al., 2010; Rana, Aloisio, Choi, & 
Barber, 2018). However, these regulators of the EMT morphological program are 
generally not necessary for transcriptional events with EMT. This correlated with our 
results, as we could observe that the knockout of FMNL2 had no effect on the induction 
of the transcriptional program. Smad2 was timely phosphorylated after stimulation with 
TGF and the epithelial markers were downregulated in the WT and FMNL2 KO 
MCF10A cell lines, with an upregulation of the mesenchymal markers. 
5.2 PKC alpha upregulation in response to TGF and FMNL2 phosphorylation 
 
Regulation of PKC activity by TGF has been previously reported. TGF stimulation 
increases PKC mRNA, expression, and activity in fibroblasts (Gao et al., 2003a).  
PKC  further interacts with TGF receptor I and promotes its endocytosis in podocytes 
(Tossidou et al., 2009). Moreover, PKC phosphorylates Smad3 downstream of TGF 
signaling leading to down-regulation of growth inhibitory and apoptotic action of 
TGF (YAKYMOVYCH IHOR, PETER TEN DIJKE, CARL-HENRIK HELDIN, 2001). 
MCF10A cells are immortalized but non-transformed and non-tumorigenic, and we do 
not expect elevated PKC activity since that is found in human breast tumors (Kazanietz, 
2015). This cell line expresses very low levels of PKCα and therefore offers a low 
background for experiments seeking to correlate overexpression of PKCα with its 
phenotypic consequences. Of the diacylglycerol (DAG)-sensitive isoforms expressed in 
these cells, PKCα is the only Ca2+/DAG-dependent (conventional) isoform (Abeyweera, 
Chen, & Rotenberg, 2009). The upregulation we observe after TGF stimulation is in line 
with previous literature (Gao et al., 2003b; Zhou et al., 2009). Inhibition of FMNL2 
phosphorylation upon BIM addition further confirms PKC involvement in our suggested 
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signaling pathway. This endorses our hypothesis where the phosphorylated form of 
FMNL2 is playing the more dominant and functional role during the initiation and 
execution of the EMT process following TGF stimulation.  
 
5.3 ANGPTL4 as an FMNL2 interaction partner  
 
Our experiments revealed ANGPTL4 as a cellular binding partner to FMNL2 under 
TGF-induced EMT conditions. ANGPTL4 binding appeared to be specific to the 
phosphorylated form of FMNL2, as the phospho-mutant (S1072A) showed no interaction 
in the immunoprecipitation assay. No other formins have been associated with 
endogenous ANGPTL4. Hence, the novelty of this interaction between an actin regulator 
and a matricellular glycoprotein is of great interest. Importantly, both FMNL2-NT and CT 
were able to directly interact with ANGPTL4. However, only the ANG NT showed an 
interaction with FMNL2. This could be due to the fact that ANGPTL4 has a predicted 
transmembrane domain in its NT which causes it to locate at cellular membranes and 
interact with FMNL2. The prediction software used determines the presence of alpha-
helical membrane spanning regions. This has yet to be further verified experimentally, 
by X-ray or crystallography. We could not explain binding of ANGPTL4 to the C-terminal 
domain of FMNL2. However, removal of the signaling peptide was essential for the 
protein purification of ANGPTL4. We speculate that this could play a role in yielding 
unspecific interactions since the signaling peptide plays a role in proper targeting of the 
protein to the membrane and hence its possible interaction partners. To clarify this, we 
aim to perform Immunogold electron microscopy and use an antibody directed towards 
the N-terminus of ANGPTL4. We also consider isolating vesicles after TGF stimulation 
and probing for ANGPTL4-NT or ANGPTL4-CT to determine which form is more 
abundant, and hence is more probable to be interacting with FMNL2. Another option is 
obtaining a membrane-bound organelle fraction through membrane fractionation and 
probing for FMNL2 and/or ANGPTL4-NT. We can also attempt to mutate the putative 
transmembrane region of ANGPTL4 to abolish the ANGPTL4-FMNL2 interaction. Even 
though the cleavage site of ANGPTL4 is recognized, the distribution of the different 
isoforms and their tissue specificity is still not well defined. We assume that the cleavage 
is occurring either in the vesicles, or after ANGPTL4 secretion. Proprotein convertases 
such as Furin are enriched in the Golgi apparatus and are known to cleave ANGPTL4 
(Lei et al., 2011). It would be of great interest to identify exactly which ANGPTL4 isoform 
is prevalent in our cell line and pinpoint its respective interaction with FMNL2.  
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We further show a critical role for FMNL2 in promoting the secretion of ANGPTL4 protein 
from secretory vesicles where FMNL2 KO diminishes the level of secreted ANGPTL4. 
Addition of different inhibitors targeted against actin (Latrunculin), formins (SMIFH2), or 
PKCs (BIM) showed no effect on the level of secretion. This could be due to the fact that 
we used low concentrations since the treatment was for a long period of 48 hr. Moreover, 
recent studies have implicated the role of formin mDia2 in stabilizing microtubules 
independently of their actin polymerization activity (Bartolini et al., 2008). Formins 
regulate cytoskeletal coordination where they mediate cross-talk between actin and 
microtubules. Hence, perhaps FMNL2 plays a role in regulating microtubules and the 
subsequent vesicle transport (Hehnly & Stamnes, 2007) or exocytosis (Müller et al., 
2019). To test this, we could use the microtubule inhibitor nocodazole and monitor if 
secretion levels of ANGPTL4 are affected. Furthermore, ANGPTL4 was found to be 
accumulated in the Golgi and not in the extracellular matrix with the FMNL2 knockout or 
phospho-mutant background. This verifies that the absence of native FMNL2, and further 
phosphorylation, causes a secretion defect preventing ANGPTL4 release. The live 
imaging of FMNL2 and ANGPTL4 after TGF stimulation further confirmed this 
interaction and helped visualize the process of ANGPTL4 secretion. 
Recently, loss of FMNL2/3 has been shown to result in altered Golgi architecture and a 
defect in anterograde vesicle trafficking (Kage, Steffen, et al., 2017). It is conceivable 
that FMNL-generated actin filaments might serve mechanical functions at the Golgi and 
during trafficking processes. Actin filaments are thought to contribute to the maintenance 
of the flattened shape of Golgi cisternae, and can facilitate membrane deformations 
driving processes such as vesicle formation, scission and fusion (Egea et al., 2013; 
Gurel, Hatch, & Higgs, 2014). However, we cannot exclude the crucial involvement of 
microtubules and their required interplay with actin to orchestrate vesicle trafficking. We 
conclude that FMNL2 and its further phosphorylation prompt the release of ANGPTL4 
from secretory vesicles to the extracellular matrix. 
 
5.4 Cell-cell contact changes accompanied by loss of FMNL2/ANGPTL4 
In the human breast epithelial cell line MCF10A, FMNL2 specifically localizes to newly 
forming cell-cell contacts in 2D monolayers and 3D-cultured cells. Of note, in MCF10A 
cells depleted for FMNL2, contact formation but not lamellipodia protrusion was 
impaired, suggesting a cell-cell adhesion specific role for this formin. Consistent with this 
idea, FMNL2 physically associates with the junctional proteins -catenin and E-cadherin, 
and the latter interaction is increased upon Rac1 activity (K Grikscheit et al., 2015). 
ANGPTL4 is a novel matricellular protein that was reported to interact with specific ECM 
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proteins and integrins to facilitate cell migration during wound healing. Matricellular 
proteins are extracellular matrix (ECM)-associated glycoproteins secreted by cancer 
cells and neighboring stromal cells into the environment. These proteins modulate cell-
matrix interaction and are important factors in tumor progression (Wong & Rustgi, 2013). 
ANGPTL4 is highly expressed in metastatic cells, it enhances vascular permeability and 
promotes the metastasis of breast tumor cells to the lung and the metastasis of 
melanoma cells to the brain. Neutralizing antibody against cANGPTL4 resulted in tumor 
regression, reducing vascular disruption and thus, metastasis (Dao et al., 2019). Cells 
with FMNL2 KO and ANGPTL4 silencing failed to disrupt their cell-cell contacts and 
proceed through the EMT process. However, this phenotype could be rescued in the 
FMNL2 KO cell upon addition of recombinant ANGPTL4 and cell-cell contact 
disassembly presumed. These data point towards a cooperative function of FMNL2 and 
ANGPTL4 in modulating cell-cell contact integrity. Hence, in the absence of ANGPTL4 
protein we can predict a decrease in the disruption of cell-cell contacts, less migration, 
and reduced metastasis. It would be of interest to observe the effect of Rac silencing in 
addition to ANGPTL4 silencing on cell-cell contacts’ maintenance. 
5.5 FMNL2 and ANGPTL4 are required for TGF-induced invasion 
Finally, we show that the formin FMNL2 is critically involved in TGF-induced cancer cell 
invasion through 3D matrices. This experiment closely models amoeboid migration. In 
this experimental setup, migration requires that the cells identify pores in a membrane 
and squeeze through as single cells. Knockout of FMNL2 robustly diminishes the 
acquired invasive potential of MCF10A cells. This is in part consistent with recent findings 
showing that the knockdown of FMNL2 in A375 melanoma cell lines decreased their 
invasive potential (Wang et al., 2015). In addition, more ample evidence on the role of 
FMNL2 in cellular invasion further suggests and asserts that FMNL2 exerts migratory 
functions in cancer cells (Gardberg, Heuser, Koskivuo, Koivisto, & Carp En, n.d.; Kitzing 
et al., 2010; You Li et al., 2019; Péladeau, Heibein, Maltez, Copeland, & Copeland, 
2016b; Zhong, Wang, Xu, & Kong, 2018; X.-L. Zhu et al., 2011; X. L. Zhu, Liang, & Ding, 
2008b). Previously, other members of the DRF family have been demonstrated to play 
a role in invasive migration. mDia (Dia1) has been implicated in bleb-associated cancer 
cell invasion and knockdown of mDia1 efficiently inhibited the number of invading cells 
as well as the overall invaded distance (Kim et al., 2016). Two recent paper find mDia to 
be further involved in the EMT process as well (Rana et al., 2018; X.-L. Zhu et al., 2011). 
Thus, several formins appear to be relevant actin regulators for cancer cell motility and 
invasion either with overlapping or possibly with specific roles for different tumor cell 
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types and entities. These data strongly argue for a crucial and regulatory interaction 
between the formin FMNL2 and ANGPTL4 for invasive cell migration. We can speculate 
that the rounded and rapid single cancer cell motility is more efficient in seeding distant 
metastasis than the collective, mesenchymal mode of migration. The exact mechanism 
by which FMNL2 silencing reduces this kind of migration remains unexplained. It is 
possible that a subtle disruption of cell membrane structures affects their ability to sense 
the serum gradient, identify the pores or form focal complexes for adhesion. It is of 
importance here to clarify the role actin could essentially be playing in the invasive 
process. For that purpose, we will transduce FMNL2 KO cells expressing an actin-
binding deficient mutant and test their invasion capacity. 
ANGPTL4 has also been described to play a role in cancer cell invasion in breast and 
melanoma cancer models where cellular invasion is critically dependent on ANGPTL4 
expression (Adhikary et al., 2013; Y. Sun, Long, & Zhou, 2014). Silencing of ANGPTL4 
in our model further reduced the invasion capacity of the most invasive cell lines (WT 
and FMNL2-overexpressing). Here, we suggest that through the described interaction of 
ANGPTL4 with junctional components (Huang et al., 2011) and in line with our previous 
section (5.4), that ANGPTL4 plays a role in disrupting cell contacts to promote invasion. 
This indicates the dual role FMNL2 and ANGPTL4 play in modulating TGF-induced 
cellular invasion.  
 
5.6 Conclusion 
 
In our study, we predicted a novel binding partner of the Formin-like 2 during TGF-
induced epithelial mesenchymal transition. Initiating EMT in our non-transformed cell line 
led to PKC-alpha upregulation resulting in the activation of FMNL2 through a phospho-
switch. We recognized Angiopoietin-like 4 to interact through its N-terminus with FMNL2 
at cellular membranes. FMNL2 promotes ANGPTL4 secretion from intracellular vesicles 
and both act together in modulating cell-cell contact integrity and cellular invasiveness. 
An appealing future aspect is the possibility of employing formins such as FMNL2 as 
potential drug targets and matricellular glycoproteins, such as ANGPTL4, in the 
treatment of invasive diseases and particularly cancer. 
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Figure 26. TGFβ targets Formin-like 2 for ANGPTL4 secretion in MCF10A WT cells during EMT.  
  
Representative models summarizing the TGFβ-dependent phosphorylation of FMNL2 leading to 
its role in aiding secretion of ANGPTL4 to allow the cells to undergo EMT and further on 
metastasize. 
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6. Summary 
 
 
Epithelial to Mesenchymal transition (EMT) is a highly dynamic process that plays a 
crucial role in tumor progression and metastasis. While remodelling of the actin 
cytoskeleton is a hallmark of EMT, the responsible actin regulating factors are less well 
understood. Formins are involved in numerous cellular mechanisms, ranging from 
cytokinesis to cell adhesion and motility. The Rho-GTPase effectors of the formin family 
compromise the largest group of actin nucleators and are emerging as relevant 
pharmacological targets. A critical role of Formin-like 2 (FMNL2) in the assembly of 
junctional actin at newly forming cell-cell contacts in a 3D matrix has been described. 
This activity originates downstream of Rac1 and is in line with a physical association of 
FMNL2 and components of the cadherin-catenin complex. FMNL2 was further recently 
implicated in β1-integrin trafficking as a direct PKC target required for cancer cell 
invasion.  
 
Here we found that transforming growth factor-beta (TGFβ)-driven EMT leads to an 
upregulation of PKC resulting in the phosphorylation and activation of FMNL2 in 
epithelial cells. Proteomic screening for TGFβ-mediated phospho-FMNL2 binding 
partners identified the tumor promotor ANGPTL4 as a specific binding partner. 
ANGPTL4 has important roles in cancer development and progression including 
promoting invasion and metastasis. We found that FMNL2 and ANGPTL4 directly 
interact under TGF-induced EMT. Our data show that FMNL2 is a critical regulator of 
ANGPTL4 secretion. Secretion of ANGPTL4 is diminished upon loss of FMNL2 and its 
phosphorylation. We further observed that ANGPTL4 is sequestered in the Golgi 
apparatus colocalizing with markers of the trans-Golgi network. Live imaging of vesicle 
secretion from the Golgi confirmed the transient co-localization of ANGPTL4 and 
FMNL2. Moreover, ANGPTL4 and FMNL2 modulate cell-cell contact integrity and 
ANGPTL4 silenced cells fail to disassemble their underlying cell-cell contacts to execute 
EMT. This effect was further enhanced upon FMNL2 knockout using FMNL2 
CRISPR/Cas9 cell line. However, re-introduction of ANGPTL4 restored the 
mesenchymal phenotype and prompted the dissolution of cell-cell adhesions. Finally, we 
found that cellular invasion promoted by TGFβ depends on FMNL2 and is reduced upon 
ANGPTL4 silencing. Taken together, our data point towards a crucial role of FMNL2 for 
EMT via ANGPTL4 secretion. 
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Zusammenfassung  
 
Epithelial-to-Mesenchymal Transition (EMT) beschreibt einen hochdynamischen 
Prozess, bei dem Epithelzellen Differenzierungsmerkmale mesenchymaler Zellen 
entwickeln. Dies spielt eine entscheidende Rolle bei der Tumorprogression und 
vereinfacht die Metastasierung von Krebszellen. Als Grundlage von EMT sind 
strukturelle Veränderungen im Aktinzytoskelett notwendig, jedoch sind die 
verantwortlichen, aktinregulierenden Faktoren nur unzureichend charakterisiert. 
Formine stellen hierbei eine Proteinfamilie dar, die an zahlreichen, zellulären Prozessen, 
wie der Zytokinese, der Adhäsion und der Motilität beteiligt ist. Als Rho-GTPase-
Effektoren formen Formine die größte Gruppe bekannter Aktinnukleatoren und 
neuerdings auch pharmakologisch relevante Ziele. In diesem Kontext wurde eine 
entscheidende Rolle von Formin-like 2 (FMNL2) bei der Assemblierung von 
Aktinstrukturen an de novo gebildeten Zell-Zell-Kontakten in 3D-Zellkulturmodellen 
beschrieben. Diese Aktivität entsteht abwärts von Rac1 sowie durch eine direkte 
Interaktion von FMNL2 und Komponenten des Cadherin-Catenin-Komplexes. Darüber 
hinaus wurde eine Phosphorylierung von FMNL2 durch PKC als essentiell für den 
zellulären Stoffwechseln von β1-Integrinen und damit für die Invasion von Krebszellen 
herausgestellt. 
 
In der vorliegenden Arbeit zeigen wir, dass die Transforming Growth Factor-beta 
(TGFβ)-induzierte EMT zu einer erhöhten Expression von PKC führt, die in einer 
aktivierenden Phosphorylierung von FMNL2 in Epithelzellen resultiert. Das 
proteomische Screening von Phospho-FMNL2-Bindungspartner nach Behandlung mit 
TGFβ lieferte den Tumorpromotor ANGPTL4. ANGPTL4 spielt eine wichtige Rolle bei 
der Tumorentstehung und -progression, einschließlich der Förderung von Invasion und 
Metastasierung. Wir konnten nachweisen, dass FMNL2 und ANGPTL4 im Rahmen der 
TGFβ-induzierten EMT direkt interagieren. Unsere Daten weisen darauf hin, dass 
FMNL2 ein kritischer Regulator der ANGPTL4-Sekretion ist, da die Sekretion von 
ANGPTL4 durch den Verlust von FMNL2 und dessen Phosphorylierung verringert wird. 
Wir beobachteten weiterhin, dass ANGPTL4 im Golgi-Apparat mit Markern des trans-
Golgi-Netzwerks kolokalisiert. Lebendzellmikroskopie der Vesikelsekretion aus dem 
Golgi-Apparat bestätigte die transiente Kolokalisation von ANGPTL4 und FMNL2. Des 
Weiteren modulieren ANGPTL4 und FMNL2 die Integrität von Zell-Zell-Kontakten, da 
ANGPTL4-defiziente Zellen Zell-Zell-Kontakte nicht zerlegen können, um EMT 
auszuführen. Dieser Defekt war bei Verlust von FMNL2 in einer FMNL2-CRISPR/Cas9-
Zelllinie verstärkt. Eine ektopische Expression von ANGPTL4 stellte den 
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mesenchymalen Phänotyp wieder her und bewirkte die Auflösung von Zell-Zell-
Kontakten. Schließlich fanden wir heraus, dass die TGFβ-induzierte Zellinvasion von 
FMNL2 abhängt und durch Verlust von ANGPTL4 reduziert wird. Zusammengenommen 
weisen unsere Daten auf eine essentielle Rolle von FMNL2 für die ANGPTL4-Sekretion 
und damit EMT hin. 
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